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Cereal fibers that can be metabolized by gut microbiota have been shown to promote the growth of 
beneficial bacteria in the gut. Increased consumption of cereal fibers may improve host / gut microbiota 
interactions in obesity and other metabolic diseases by normalizing gut dysbiosis. The present dissertation 
describes four research projects to assess the impact of cereal dietary fibers on gut microbiota and host 
metabolism. In the first study, we determined the treatment temperatures for production of soluble, non-
digestible, feruloylated oligo- and polysaccharides (FOPS) from maize bran and wheat bran, and 
determined the fermentation properties of partially purified FOPS from maize bran and wheat bran. In vitro 
fermentation revealed that wheat FOPS were more bifidogenic than maize FOPS. However, maize FOPS 
led to continual production of short-chain fatty acids (SCFA), resulting in the highest SCFA and butyrate 
production at the end of the fermentation. In addition, maize FOPS showed significantly higher antioxidant 
activity than wheat FOPS. The study showed FOPS from maize bran may exhibit enhanced benefits on gut 
health compared to those of wheat bran. In the second study, we further determined whether the colonic 
fermentation of FOPS could counteract the deleterious metabolic effects of a high-fat (HF) diet through 
modulating the gut microbiota using a mouse model. Our results suggest that colonic fermentation of FOPS 
plays an important role in preventing metabolic disorders in HF-fed mice, and that these metabolic 
improvements depend on specific alterations of the gut microbiota through FOPS fermentation. Blautia and 
Akkermansia might be considered potential therapeutic targets for improving body and adipose tissue 
weights, while SCFA production seems linked to improvements in glucose metabolism. In the third study, 
by obtaining long-term dietary records from fecal donors, we aimed to determine the correlations between 
dietary intake variables and dietary fiber degradation and short-/branched-chain fatty acid (BCFA) and 
ammonia production during in vitro fecal fermentation. We found that butyrate production was correlated 
with fecal donor intake of many nutrients, of which principal component analysis revealed were mostly 
  
contributed by grain-, nut-, and vegetable-based foods. Negative correlations were found for propionate 
with intake of total carbohydrate, added sugar, and sucrose and for ammonia and BCFA production with 
intake of unsaturated fats. These results suggest that diets high in plant-based foods and high in unsaturated 
fats are associated with microbial metabolism that is consistent with host health. In the fourth study, we 
determined the impacts of long-term dietary pattern on gut microbiota composition and the change in 
composition of the gut microbiota during fermentation of predigested whole wheat flour. Butyrate 
production was significantly correlated with the abundance of Butyricicoccus, Coprococcus, Dorea, 
Faecalibacterium, and Lachnospiracea incertae sedis. BCFA and ammonia production displayed negative 
correlations with the abundance of Roseburia and Parasutterella. Bifidobacterium and Butyricicoccus were 
enhanced by pre-digested whole wheat flour. Taken together, these results provide new evidence for 
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This dissertation is organized as follows: a literature review (Chapter 1) followed by manuscripts 
describing four research projects (Chapters 2, 3, 4, and 5).  Chapter 1 provides a review of the current 
literature on the impacts of native and processed cereal grain fibers on the gut microbiota. This chapter has 
been formatted using the guidelines for Journal of Food Science; Chapter 2 describes our study on 
production and in vitro evaluation of soluble, non-digestible, feruloylated oligo- and polysaccharides 
(FOPS) from maize bran and wheat bran. This chapter has been formatted for Journal of Agriculture and 
Food Chemistry; Chapter 3 describes the results on the effect of maize-derived FOPS on the metabolic 
disorders and gut microbiota using an in vivo mouse model. This chapter has been formatted for Molecular 
Nutrition & Food Research; Chapter 4 describes results on the correlations between dietary intake 
variables and dietary fiber degradation and short-/branched-chain fatty acid (BCFA) and ammonia 
production during in vitro fecal fermentation. Chapter 5 describes results on the impacts of long-term 
dietary pattern on gut microbiota composition and the change in composition of the gut microbiota during 
fermentation of predigested whole wheat flour. Chapters 4 and 5 have been formatted for Nutrition 
Research. It is noted that materials presented in Chapters 2 and 4 have already been published. 
Hypotheses: 
Chapter 2: Because the parent polymer of FOPS, maize heteroxylan, ferments more slowly with higher 
production of SCFA than other arabinoxylans, we hypothesized that FOPS from maize would be more 
bifidogenic and support bacterial fermentation the longest and produce the highest SCFA compared with 
FOPS from wheat, thus possibly contributing to a colonic environment that is less susceptible to disease. 
Chapter 3: We hypothesized that unique structural diversity coupled with the presence of antioxidants in 
FOPS would aid in the improvement of insulin response and lipid profile, alleviating the inflammation 
syndromes, sustaining prolonged bacterial fermentation, and altering the gut microbiotia to a healthier state. 
Chapter 4: Because diet influences gut microbiota, we hypothesized that diet would impact the extent of 
dietary fiber utilization and the types of metabolic end-products produced by the microbiota during in vitro 
fecal fermentation. 
Chapter 5:  We hypothesized that long-term dietary pattern and the fermentation of whole grain wheat 




Chapter 2:  To determine treatment temperatures for production of FOPS from maize bran and wheat bran 
and determine the fermentation properties of partially purified FOPS from these substrates. 
Chapter 3: To determine if consumption of maize-derived FOPS could counteract the deleterious effects 
of high-fat (HF) feeding and modulate the gut microbiota in mice. 
Chapter 4: To determine the correlations between dietary intake variables and dietary fiber degradation 
and short-/branched-chain fatty acid (BCFA) and ammonia production during in vitro fecal fermentation. 
Chapter 5: To determine the influence of long-term dietary pattern and the fermentation of whole grain 
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Chapter 1 . Modulating the gut microbiota using native and processed cereal grain fibers 
1. Abstract 
The human gut is colonized by trillions of microorganisms, which form a complex microbial 
system. This super organ has important effects on human physiology, such as metabolizing food and 
xenobiotic compounds, contributing to the pathogenesis of metabolic diseases, and regulating colonic 
resistance against pathogenic bacteria. Dietary interventions with cereal-based foods have been proposed to 
modulate the gut microbiota. Considering the unique chemical and physiological properties of cereal fibers 
and their attached antioxidants, these compounds may serve as important candidates for dietary 
intervention to elicit beneficial effects by altering the gut microbiota to a healthier state. However, the rigid 
structure and poor colonic fermentability of these non-digestible components in cereal grains may limit the 
utilization of these fibers by the gut microbiota. A variety of novel processing techniques, including 
enzymatic treatment, hydrothermal treatment, extrusion, chemical extraction, supercritical CO2 treatment, 
and ozonolysis treatment, may be considered to increase the utilization of cereal fibers.  
2. Gut microbiota 
The human gut harbors a vast array of microorganisms that form a complex microbial system. The 
commensal bacteria of the human microbiota typically include five microbial phyla: Firmicutes, 
Bacteriodetes, Antinobacteria, and Proteobacteria. Firmicutes and Bacteroidetes typically representing 
over 90% of the total gut microbiota for most individuals (Prakash and others 2011). Most of the gut 
microbiota are non-culturable, but this notion has recently challenged by Goodman et al., (Goodman and 
others 2011) who reported that 99% of the bacteria that were characterized in the phylum, class, and order 
levels could be detected in a cultured fecal sample. 
The colonization of the gut mcirobiota starts at birth, and the microbial composition changes 
through different stages of life. The infant acquires a gut microbiota from his or her mother and the 
environment. The most commonly isolated microorganisms from newborn feces are Staphylococcus spp., 
Enterobacteriaceae, and Streptococcus spp (Di Gioia and others 2014), but the infant gut microbiota has a 
relatively simple structure and is unstable over time. Even different feeding strategies may affect the gut 
microbiota significantly. For instance, breast-fed infants have a less complex gut microbiota that is 
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dominated by Bacteroides spp. and Bifidobacteria (over 90% of the total) compared with formula-fed 
infants (Di Gioia and others 2014). Ecological and evolutionary forces lead to a more stable microbiota in 
adults by shaping the microbial diversity.  Later, a set of age-related shifts in the composition and function 
of the gut microbiota may occur,  for instance, a significant decrease in Bifidobacteria and a decline in 
immune system responses, occur after the age of 60 years (Nicholson and others 2012). 
In addition to the mother‘s impact at birth, other factors have been suggested to influence the gut 
microbiota. First, the host genetic background may contribute to the individuality of the microbiota. Studies 
performed using mouse models indicated the linkage of quantitative trait loci (QTL) with specific 
microbiota composition, confirming the importance of genetic control in shaping the diversity of the 
microbiota (Benson and others 2010). Second, environmental factors, such as diet and exercise, have also 
been proposed as a driving force for the gut microbiota (Petriz and others 2014; Clarke and others 2014). 
The gut microbiota has a huge metabolic capacity and can complement functions that have not 
developed within the human body (Round and Mazmanian 2009), making the microbiota a ―super organ‖ 
that is responsible for the digestion of complex food/drug components, metabolism and energy harvesting, 
colonization resistance and other functions (Round and Mazmanian 2009; O'Keefe 2008). 
3. The role of the gut microbiota in human physiology 
3.1. Gut microbiota and food/xenobiotic metabolism 
 The gut microbiota can either produce harmful metabolites associated with human diseases or 
beneficial components that protect against diseases, depending on dietary intake (O' Keefe and others 2015). 
For instance, the toxic effect of melamine in infant milk is mediated by the biotransformation of this 
compound by certain gut microbiota (Zheng and others 2013). Moreover, the gut microbiota can 
metabolize dietary L-carnitine from red meat to trimethylamine-N-oxide, which is a proatherogenic 
compound (Koeth and others 2013), while the production of short chain fatty acids (SCFA) from 
carbohydrate fermentation, vitamins and conjugated linoleic acid may have beneficial health effects. 
Although we still have a limited understanding of the metabolism of different compounds by the gut 
microbiota, carbohydrate and polyphenol metabolism have been well studied.  
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Fruit, vegetables, and cereals are the major dietary components that provide dietary fibers for the 
microbiota. Thanks to at least 81 different glycoside hydrolase families, these fibers can be metabolized to 
sugars by the gut microbiota; these sugars are fermented to SCFA, including acetate, propionate, and 
butyrate. These SCFA can trigger the secretion of the hormone GLP-1, resulting in increased of insulin 
secretion and decreased feeling of hunger (Tolhurst and others 2012). Specifically, butyrate, which is a 
preferred energy source of gut epithelial cells, has been shown to promote energy expenditure and improve 
insulin sensitivity in a mouse model (Gao and others 2009). Saccharolytic fermentation is important 
because it may create a beneficial gut environment, in contrast, when carbohydrates are in short supply, the 
gut microbiota will switch to the fermentation of amino acids, resulting in the release of harmful 
metabolites including branched chain fatty acids (BCFA) and ammonia (Van Nuenen and others 2004).  
In addition to the complex carbohydrates, polyphenols are other non-digestible components in our 
daily diet than can be metabolized to a large extent by the gut microbiota, yielding products such as 
hydroxyphenylacetic, phenylpropionic, and phenylbutyric acids, which have potential health benefits 
(Saura-Calixto 2010). For instance, the 3, 4-dihydroxyphenylacetic and 4-hydroxyphenylacetic acid 
metabolites have shown higher inhibition of platelet aggregation than their precursors (rutin or quercetin) 
(Kim and others 1998). The hydroxyphenylacetic and phenylpropionic derivatives from the microbial 
degradation of flavonoids have been linked to inhibited endothelial dysfunction (Schewe and others 2008). 
3.2. Gut microbiota and metabolic diseases 
   Metabolic syndrome (including insulin resistance, hyperglycemia, hypertension, and dyslipidemia) 
is a cluster of obesity-related disorders that affects 35% of adult Americans (Jialal and others 2014). The 
increasing metabolic syndrome epidemic results from an energy imbalance that involves the consumption 
of more calories than expended and is characterized by increased risk of type-2 diabetes and other 
metabolic diseases. Recent studies have suggested the existence of a strong association between the gut 
microbiota and metabolic syndrome (D‘Aversa and others 2013; Festi and others 2014). 
3.2.1. Gut microbiota and obesity 
 The first study to link obesity with the gut microbiota profile was conducted in genetically obese 
mice and reported that obesity is associated with different microbiota at the phylum level, with an increased 
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prevalence of Firmicutes and a decreased prevalence of Bacteroidetes in obese mice in comparison to their 
lean counterparts (Turnbaugh and others 2008).  Consistent with the mouse data, the first human study also 
showed a higher proportion of Bacteroidetes in normal weight individuals than in obese individuals (Ley 
and others 2006). However, some subsequent studies have reported differing results. For instance, Collado 
et al. reported a significantly higher level of Bacteroidetes in overweight women than in normal-weight 
individuals (Collado and others 2008). The failure of the Human Microbiome Project to find an association 
between the Firmicutes/Bacteroidetes ratio and obesity also raise the questions about whether this ratio 
should be associated with obesity (Moran and Shanahan 2014).  
Compositional changes in the gut microbiota in response to weight loss have been reported, but 
the results are also inconsistent. For instance, Schwiertz et al. reported a decrease in Bacteroidetes after 
weight loss (Schwiertz and others 2010), while Duncan et al. reported no change in Bacteroidetes after a 4-
week carbohydrate-reduced diet (Duncan and others 2008). These mixed results may be explained by the 
complexity of the gut microbiota and the existence of large individual differences. 
 Rather than compositional differences at the phylum level, species-level bacterial differences are 
more likely to be responsible for the association between diseases, such as obesity, and the gut microbiota, 
because the function of gut microbiota diverges at the species level (Tuohy and Del Rio 2014). For instance, 
the consumption of Bifidobacterium longum decreased the expression of genes that encode inflammatory 
cytokines, but the ingestion of Bifidobacterium. animalis subsp. lactis elicited a different effect, resulting in 
an increase in anti-inflammatory cytokines (Furrie 2006; Arunachalam and others 2000). Moreover, 
Akkermansia muciniphila, which is a mucin-degrading bacterial species, has been inversely correlated with 
body weight in rodents and humans (Everard and others 2013). A previous study also demonstrated the 
specific function of A. muciniphila, including the reversal of high fat-induced weight gain, adipose 
inflammation, and insulin resistance (Everard and others 2013).  
 Although recent studies have suggested the core microbiota composition is associated with 
different health or disease states, such as obesity, the problem of whether an altered gut microbiota causes 
the obese state or the obese state results in an altered gut microbiota is of interest. The applicability of the 
results to humans is in debate because the physiology and metabolic pathways of these animals are quite 
different from those of animals with conventional gut flora. An emerging view suggests that the gut 
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microbiota is characterized by a core metabolic function rather than by certain types of bacteria; thus, even 
distantly related bacteria share similar key metabolic functions and these key metabolic functions are 
directly related to health or disease (Tuohy and Scott 2015).  For instance, the gut microbiota may impact 
the genesis of obesity through metabolic products or between microbiota-host signaling.  
Potential mechanisms that link the gut microbiota with obesity have been proposed. First, through 
the digestion of complex dietary carbohydrates, the gut microbiota can produce SCFA, including acetate, 
propionate, and butyrate. These organic acids not only represent an energy source, but also trigger cell-
specific signaling cascades, regulating energy harvest. For instance, G-protein coupled receptors (GPCRs), 
GPR41 and GPR43 have been shown to be activated by SCFA, eliciting cascade reactions. The activation 
of GPR 41 can enhance the secretion of peptide YY (PYY) from intestinal L cells, inhibiting gastric 
emptying and food intake, whereas the activation of GPR43 is reported to inhibit fat accumulation in the 
adipose tissue and trigger the secretion of GLP-1, which is a peptide that inhibits gastric emptying and food 
intake (Everard and Cani 2014; Kimura and others 2014). Second, the gut microbiota can regulate host 
metabolism by regulating bile acids. Bile acids reach the colon, where they can affect the composition of 
the gut microbiota and are also modified by the gut microbiota (Joyce and others 2014). The primary 
function of bile acids is to emulsify dietary lipids and fat-soluble vitamins, but these acids can also act as 
signaling molecules for two different receptors in the host: cellular farnesoid X receptor (FXR), which 
controls the transcription of genes that affect glucose and lipid metabolism, and TGR5, which increases 
GLP-1 secretion (D‘Aversa and others 2013). Another study suggested that the bile salt hydrolase activity 
(BSH) of gut microbiota plays an important role in energy homostasis.  Significant reductions in weight 
gain, serum cholesterol, and liver triglycerides were observed in mice with elevated BSH activity (Joyce 
and others 2014). Third, by acting on the mucus thickness or tight junction proteins, the gut microbiota may 
regulate the gut permeability, resulting in the genesis of low-grade inflammation that is characteristic of 
obesity and many obesity-associated disorders (Cani and others 2009). Cani et al. has suggested that 
lipopolysaccharide (LPS), which is a constituent of gram-negative gut bacteria, may act as a trigger for this 
inflammation, a condition known as metabolic endotoxemia (Cani and others 2009). The altered gut 
microbiota associated with increased epithelia permeability resulted in the easy translocation of LPS to the 
blood and increased plasma levels of LPS.  The LPS may subsequently be transported by a mechanism 
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involving lipoproteins and trigger the secretion of proinflammatory cytokines (e.g., TNF-a, IL-1, and IL-6) 
after binding to the CD14 and TLR4 receptors on innate immune cells (D‘Aversa and others 2013). The 
proposed mechanism by which LPS causes inflammation and obesity was established using a mouse model. 
For instance, LPS treated mice developed symptoms, such as increased body, liver, and adipose tissue 
weight gain to a similar extent as high fat-fed mice (Cani and others 2007).  
3.2.2. Gut microbiota and type-2 diabetes       
 The rapid increase in the prevalence of type-2 diabetes in the recent decades makes this disease a 
worldwide health concern. Approximately 20-25% of the world‘s population has the problem of metabolic 
syndrome, including obesity, insulin resistance, hyperglycemia, and hyperlipidemia. This population is also 
at high risk for type-2 diabetes (Alberti and others 2006). The gut microbiota plays a vital role in these pre-
diabetes metabolic syndromes, such as obesity and insulin resistance. Cani et al. established the association 
between the gut microbiota, inflammation, and pre-diabetes metabolic syndromes and suggested the 
bacterial LPS/CD14 system may regulate insulin sensitivity. CD14 has been identified as a pattern 
recognition receptor (PRR) that binds LPS. In a four-week high fat diet, wild-type mice had increased LPS 
accompanied by alternations in gut microbiota composition and insulin resistance (Cani and others 2007). 
In contrast, when CD14 knockout mice were subjected to the same high-fat diet, the genetically modified 
mice gained less weight and exhibited increased insulin sensitivity and reduced systemic inflammation 
compared with the wild-type mice. In contrast, the reinfusion of bacterial LPS to the CD14 knockout mice 
abolished all of these metabolic improvements (Cani and others 2007).  In another experiment, obese mice 
treated with an antibiotic that altered the gut microbiota and decreased endotoxemia exhibited 
improvements in insulin resistance, fasting glycemia, and inflammatory parameters compared with control 
ob/ob mice (Membrez and others 2008; Cani and others 2008). Another study linked increased bacterial 
translocation with the onset of insulin resistance. Bacterial translocation is used to describe the migration of 
viable bacteria from the gastrointestinal tract to extraintestinal sites. For instance, increased E.coli 
translocation into the blood contributed to the establishment of diabetic status, whereas a probiotic 
treatment that decreased translocation could reverse the diabetic status (Amar and others 2011). These 
results may be associated with gut permeability as discussed in the obesity section, because obesity is one 
of the most important risk factors for type-2 diabetes.  
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3.3. Gut microbiota and colonization resistance 
 Colonic resistance against intestinal pathogens is conferred primarily by the commensal gut 
microbiota, resulting in the protection of the host intestine. For instance, fecal transplants of healthy gut 
microbiota to reconstitute the gut microbiota of a patient with Clostridium difficile are highly effective in 
treating this disease (Youngster and others 2014). This phenomenon can be explained from an ecological 
perspective. The establishment of a healthy gut microbiota allows commensal organisms to occupy specific 
ecological niches according to specific nutritional states or metabolic functions. Once stability is 
established, the resilience of the gut system may protect it from infection with pathogenic bacteria. The 
colonization of commensal bacteria contributes to the homeostasis of the gut ecosystem by regulating the 
immune system and stimulating the production of antimicrobial factors (Buffie and Pamer 2013). This 
phenomenon is of interest because with increased antibiotic therapy, antibiotic-resistant bacteria in the gut 
may proliferate in the intestinal lumen, posing a serious health threat.   
4. Impacts of cereal fibers on gut microbiota 
  Due to the important physiological influence of the gut microbiota and its metabolic products, the 
gut microbiota is an important target, especially in the management of obesity and related metabolic 
diseases. Diet is a critical driving force that contributes to the diversity of the human gut microbiota. 
Numerous studies have focused on the influence of long-term diet on the gut microbiota composition. For 
instance, the fecal microbiota from people with high fiber consumption is enriched for Prevotella and 
Xylanibacter (De Filippo and others 2010). Long-term intake of protein and animal fat resulted in the 
enrichment in Bacteroides, whereas long-term intake of carbohydrates was associated with Prevotella (Wu 
and others 2011). In addition to the long term diet, David et al. suggested that even a short-term drastic 
dietary change has impacts on the gut microbiota. Ten subjects were recruited and consumed either a plant-
based diet or an animal based diet for five days. In response to the plant diet, the gut microbiota became 
better at breaking down carbohydrates  and producing SCFA, while in response to the meat diet, the gut 
microbiota changed their metabolism by achieving more genes for breaking down harmful chemicals in 
meat and producing the products of amino acid fermentation (David and others 2013). 
 Two mechanisms are proposed regarding the impact of diet on the gut microbiota. First, different 
bacteria vary in the capacity to utilize substrates, which is determined by their genomes. The competition 
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for different substrates decides the relative abundance of the bacteria (Flint and others 2014). This principle 
makes it possible to manipulate the gut microbiota using  probiotics or prebiotic-related substances. Second, 
dietary factors may change the gut environment, and different bacteria vary in their tolerance to this 
environment, such as the pH or mineral concentrations (Flint and others 2014). 
 Evidence continues to mount concerning the manipulation of the gut microbiota using prebiotics 
(Delzenne and others 2011). For instance, fructans and galactooligosaccharides have attracted great interest. 
However, the intake of these oligosaccharides in most diets (1-4 g/d) [17] is small in comparison with the 
quantities of cereal fiber that are the typical substrates for gut bacteria (11-20 g/d) [18].  
Epidemiological studies have associated the intake of whole grains with a reduced risk of many 
metabolic diseases. Most studies also demonstrated that whole grains can protect against weight gain and 
obesity. For instance, in three studies that were based on food frequency questionnaires including 3559 
participants, whole grain intake was inversely associated with weight gain (McKeown and others 2002; 
Newby and others 2003).  In a study that examined adults in Great Britain from 1986-87 and 2000-2001, an 
inverse association between whole grain intake and obese population was observed (Thane and others 
2007). Other studies have linked whole grain consumption with reduced risk of metabolic diseases. In a 
meta-analysis of prospective cohort studies, an inverse association between whole grain intake and type 2-
diabtes was reported (de Munter and others 2007).  In a cross-sectional study of 2941 subjects, increased 
intake of whole grain was associated with reduced risk factors for metabolic syndrome, such as fasting 
insulin (McKeown and others 2002). 
However, intervention studies that have focused on the physiological effects of consuming a 
whole grain diet are inconsistent. Giaco et al. examined 60 women and men with metabolic disease who 
received a whole grain-based diet or a refined-cereal diet and found significant decreases in postprandial 
insulin and triglycerides in the whole grain group (Giacco and others 2014). A randomized controlled trial 
reported decreased satiety and improved blood glucose response after the consumption of cereal based food 
with enriched wheat and pea fiber compared with the refined bread (Gonzalez-Anton and others 2015).  
Another randomized, controlled, single-blind, cross-over study showed that insulin sensitivity improved 
after increased insoluble oat fiber intake (31.2g/d) for just 3 days (Weickert and others 2006).  However, 
other studies reported no significant effects of whole grain consumption.  For instance, Andersson et al. 
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found no difference between obese subjects who consumed a whole grain-based diet and obese subjects 
who consumed a refined wheat diet with respect to insulin sensitivity or markers of inflammation 
(Andersson and others 2007). In another study of 102 healthy individuals, no differences in plasma Low-
density lipoprotein, cholesterol, and glucose were observed between subjects on a refined wheat diet and 
subjects on an oat fiber-rich diet (Chen and others 2004). 
Attention has been focused on the physiological effects of the cereal polysaccharide moiety (i.e., 
prebiotic effects) and the antioxidant compounds associated with the polysaccharides.   
Cereal polysaccharide moiety has heterogeneous chemical structures and is classified as soluble 
DF (SDF) and insoluble DF (IDF) based on its water solubility. Typically, the IDF is the predominant form 
in maize and wheat, while oats has a considerable amount of SDF. The beneficial effects of cereal dietary 
fiber have been well researched. For instance, administration of barley β-glucan has been shown to induce a 
strong bifidogenic effects (Mitsou and others 2010). Supplementation of water-extractable wheat 
arabinoxylan in the diet has been report to exert prebiotic effect and reduce obesity (Neyrinck and others 
2011).  
The main phenolic compounds in cereal grains are hydroxycinnamic acids, including ferulic acid, 
diferulic acid, sinapic acid, p-coumaric acid, and caffeic acid (Vitaglione and others 2008). Over 95% of 
these compounds are cross-linked with the cell walls, forming dietary fiber-phenolic compounds complexes. 
For instance, ferulic acids substitute the α-l-arabinofuranosyl moieties of arabinoxylan at C(O)-2 and/or 
C(O)-3 and are involved in oxidative cross-linkages with other arabinoxylan chains and cell wall 
components (Izydorczyk and Biliaderis 1995). Free phenolic acids have been shown to exhibit strong 
antioxidant activity and are associated with a broad range of health benefits, including anti-inflammatory, 
anti-microbial, and anti-carcinogenic activities in in vitro and animal studies (Padayachee and others 2013). 
Compared with free phenolic acids, the effects of bound phenolic compounds on human health are largely 
undetermined in vitro due to their low water solubility. Upon digestion, a lack of release of these bound 
phenolic compounds was observed in both the stomach and the small intestine (Padayachee and others 
2013). However, the colonic gut microbiota has the ability to ferment the dietary fiber fraction and release 
associated phenolic compounds. The released phenolic compounds are further metabolized by 
hydrogenation, dehydroxylation, or demethylation to produce new metabolites, including 
10 
 
hydroxyphenylacetic, phenylpropionic, and phenylbutyric acids with potential health benefits (Saura‐
Calixto and others 2010; Selma and others 2009). For instance, the 3, 4-dihydroxyphenylacetic acid, 2, 3-
dihydroxybenzoic acid, and 3-hydroxyphenylpropionic acid generated via microbial metabolism have anti-
diabetic potential in vitro, as they promote the survival and function of pancreatic beta cells (Fernández-
Millán and others 2014). Polyphenols and their metabolites have the ability to stimulate the growth of 
probiotic bacteria, such as Lactobacillus acidophilus (Hervert-Hernández and others 2009), and inhibit the 
growth of pathogenic bacteria, such as Escherichia coli (Cueva and others 2010).  However, most data 
concerning the health benefits of cereal phenol compounds is based on in vitro and animal data; more 
research in humans is needed. 
5. Novel processing treatments for cereal grains that might improve the fermentation properties of 
the dietary fibers 
 The cereal dietary fiber complex (polysaccharide moiety and antioxidants) can exert many benefits 
on gut health due to the action of the gut microbiota. However, some bacterial glucosidases and esterases 
have limited actions in breaking down the highly cross-linked dietary fiber complex. If these fibers are 
poorly fermented, their functionality, especially with respect to gut health would be limited. Therefore, a 
number of novel processing technologies have been reported, offering new ways to utilize recalcitrant bran 
products. These technologies can make cellulose/hemicellulose more accessible to enzymatic breakdown 
and lead to the increased solubilization of hemicellulosic sugars (Pérez and others 2008), thereby increasing 
the potential fermentation properties of these compounds. Although some of these treatments have only 
been studied in cereal straws, it can be speculated that increased susceptibility to enzyme attack (i.e., 
fermentation properties) would be observed if these treatments were applied to bran because of similar 
structure (Kahar 2013). 
5.1. Enzymatic treatment 
 Cell wall-degrading enzymes are the most common reagents used to treat insoluble bran materials. 
Arabinoxylan-oligosaccharides from bran have been produced using xylanase treatment (Katapodis and 
others 2003; Swennen and others 2006).  Depending on the conditions used, this method is efficient in 
releasing 30-40% of insoluble arabinoxylan (Swennen and others 2006; Rose and Inglett 2010).  Bran 
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treated with xylanase resulted in faster SCFA formation and ferulic acid release compared with native bran 
(Nordlund and others 2013).  However, the action of some types of exo-hydrolyses on insoluble dietary 
fiber led to the production of undesired monosaccharaides, causing a net decrease in dietary fiber content. 
Thus, studies have focused on selecting enzymes that act on the insoluble dietary fiber matrix and do not 
result in monosaccharide production. For instance, Napolitano et al. have reported that treating insoluble 
dietary fiber matrix with a specific preparation of  Trichoderma enzymes triples the amount of soluble 
dietary fiber without significantly reducing the total dietary fiber (Napolitano and others 2006). 
5.2. Hydrothermal treatment 
  Hydrothermal processes have been used to release the recalcitrant bran fiber complex.  The 
hydrothermal treatment of bran fraction can be performed with water (Leppänen and others 2011) using 
conventional (Rose and Inglett 2010) or microwave heating (Peng and others 2012) or by steam explosion 
with aqueous ethanol (Hongzhang and Liying 2007). Higher yields in release of insoluble structures have 
been reported for the hydrothermal compared with enzymatic treatment (Rose and Inglett 2010). However, 
the hydrothermal process may result in the formation of undesirable byproducts, such as furfural (Otieno 
and Ahring 2012), which requires the subsequent process of purification. 
5.3. Extrusion 
Mechanical stress during extrusion is responsible for the breakdown of insoluble dietary fiber, 
resulting in increases in soluble fiber (Gualberto and others 1997).  This process exhibits both high thermal 
dynamic efficiency and low cost to scale up. The impact of extrusion on the dietary fiber in bran has been 
reported. For instance, in a recent study, under the conditions of 50, 70 and 100% of the maximum 
rotations per min with the temperature ranging 161 to 180 ℃, extrusion did not affect the insoluble fiber 
content in rice and wheat bran, while a significantly increased soluble fiber content was observed in both 
types of brans (Gualberto and others 1997). Blasting extrusion processing (BEP) is a novel food processing 
technique compared with the traditional extrusion. BEP treats material with a combination of multiple 
physical phenomena including high pressure, shear stress, torque, and high temperature, resulting in fast 
processing and high throughput. BEP has also been applied to soybean residues, resulting in an ~ 11 fold 
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increase in soluble dietary fiber and ~3 fold decrease in insoluble dietary fiber, with a 30% decrease in the 
total dietary fiber (Chen and others 2014). 
5.4. Chemical extraction 
 Hemicelluloses can be solubilized by alkali. Oxidizing agents can then be used to remove lignin. 
Doner et al. reported a novel method for solubilizing and isolating arabinoxylan from destarched corn fiber. 
Alkaline hydrogen peroxide (AHP) extraction for 2h at 60 ℃ increased the yields of water-soluble 
arabinoxylan to 42% (Doner and Hicks 1997). Although the chemical method is the cheapest and easiest to 
perform, the final products are always perceived as unnatural by customers.  The production of chemical 
waste is also an environmental concern. 
5.5. Supercritical CO2 treatment 
Supercritical H2O, ammonia, and carbon dioxide (SC-CO2) can be used as potential treatment 
agents. Supercritical CO2 treatment has been applied to remove fat from rice bran, because the treated rice 
bran may be more stable for future utilization. Dietary fibers were extracted from the treated rice bran and 
displayed increased water-holding capacity and water-retention capacity compared with untreated bran 
(2010).  However, the impact of supercritical CO2 treatment on the specific structure of the dietary fiber in 
the bran remains unclear. Moreover, when subjecting rice straw to supercritical CO2 treatment at a low 
temperature, extensive porosity and lamellar structures were observed. The fiber structure becomes fluffier 
and softer, perhaps allowing more exposure to enzymatic attack (Gao and others 2010).    
5.6. Ozonolysis treatment 
Ozone may increase enzymatic hydrolysis extent of potentially fermentable sugars in wheat and 
rye straw. Increases of ~60% (wheat straw) and 40% (rye straw) in enzymatic hydrolysis yield were 
observed after ozone treatment in selected conditions (Garcia-Cubero and others 2009). The ozonolysis 
pretreatment can degrade the lignin polymer and slightly increase soluble hemicellulose content of 
lignocellulosic biomass by reacting with compounds containing  conjugated double bonds and functional 




 Recent mechanistic studies in animal and human models have provided insight into the proposed 
contributory role of the gut microbiota in metabolizing food /xenobiotic compounds, contributing to the 
pathogenesis of metabolic diseases, and regulating colonic resistance against pathogenic bacteria. 
Modulation of the gut microbiota composition or its biochemical capacity may be facilitated by dietary 
intervention. Considering the unique chemical and physiological properties of cereal fibers, these 
compounds may serve as important candidates for dietary intervention to elicit beneficial effects by altering 
the gut microbiota to a healthier state. However, the rigid structure and poor colonic fermentability may 
limit the utilization of theses fibers and further research may be focused on increasing the utilization of 
cereal fibers through novel processing techniques, including enzymatic treatment, hydrothermal treatment, 
extrusion, chemical extraction, supercritical CO2 treatment, and ozonolysis treatment. The choice should 
depend on weighing up the advantages and disadvantages of each techniques and considering the following 
factors, including equipment, cost, and nature of cereal fibers. 
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Chapter 2 . Production and in vitro fermentation of soluble, non-digestible, feruloylated oligo-and 
polysaccharides from maize and wheat brans 
1. Abstract 
High-pressure hydrothermal treatment of cereal bran results in fragmentation of the cell wall, 
releasing soluble, non-digestible, feruloylated oligo- and polysaccharides (FOPS), which may be beneficial 
to gut health. The objectives of this study were to (1) determine treatment temperatures for production of 
FOPS from maize bran and wheat bran and (2) determine the fermentation properties of partially purified 
FOPS from maize bran and wheat bran. FOPS were produced by heating bran and water (10%, w/v) in a 
high-pressure stirred reactor until the slurry reached 160–200 °C (in 10 °C increments). Final temperatures 
of 190 °C for maize bran and 200 °C for wheat bran resulted in the highest release of FOPS (49 and 50% of 
starting non-starch polysaccharide, respectively). Partial purification with ion exchange and dialysis 
resulted in a final product containing 63 and 57% total carbohydrate and 49 and 30% FOPS, respectively 
(other carbohydrate was starch). Following in vitro digestion (to remove starch), in vitro fermentation 
revealed that wheat FOPS were more bifidogenic than maize FOPS. However, maize FOPS led to continual 
production of short-chain fatty acids (SCFA), resulting in the highest SCFA and butyrate production at the 
end of the fermentation. In addition, maize FOPS showed significantly higher antioxidant activity than 
wheat FOPS. This study identified a process to produce FOPS from maize bran and wheat bran and showed 
that, considering the overall beneficial effects, FOPS from maize bran may exhibit enhanced benefits on 
gut health compared to those of wheat bran. 
2. Introduction 
The basic structure of arabinoxylan, the predominant non-starch polysaccharide in grains, is a 
(1,4)-linked β-d-xylopyranosyl backbone substituted at C(O)-2 and/or C(O)-3 with α-l-arabinofuranosyl 
moieties, some of which are themselves substituted with ferulic acid that can be involved in oxidative 
cross-linkages with other arabinoxylan chains and other cell-wall components.(1) Beyond these basic 
structures, arabinoxylan can also contain oligosaccharide side chains comprised of pentose or hexose 
sugars or uronic acids. Dependent upon botanical source and location within the kernel, arabinoxylan can 
differ in distributions and types of side chains, molecular weight, ferulate content, and degree of cross-
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linking.(1, 2) Because of its complex nature, arabinoxylan is sometimes referred to as 
glucuronoarabinoxylan or heteroxylan.(3-5) For simplicity, arabinoxylan will be used in this paper to refer 
to this complex class of polysaccharides. 
Two sources of divergent arabinoxylan structures are those from maize and wheat. Enzymatic or 
dilute acid degradation accompanied by partial methylation analysis of alkali-solubilized arabinoxylan from 
maize bran and wheat bran has revealed greater branch density and complexity in maize arabinoxylan 
compared to that of wheat. (4, 6, 7) 
In its native form, arabinoxylan is mostly insoluble and cross-linked, making it a poorly 
fermentable substrate for gut bacteria.(8-10) However, partial hydrolysis of arabinoxylan from wheat bran 
with xylanase releases arabinoxylan oligosaccharides (AXOS), which are highly fermentable in the gut and 
stimulate the growth of bifidobacteria and other beneficial bacteria.(11) AXOS have also been shown to 
reduce blood serum triglyceride and cholesterol levels, facilitate diabetic weight loss, and enhance 
antioxidant capacity in the liver.(11) 
Arabinoxylan may also be released from its insoluble matrix by autohydrolysis,(12, 13) but the 
structure of the carbohydrates released are different from those released by enzyme. For instance, 
autohydrolysis breaks down the arabinoxylan into many size pieces ranging from monosaccharides up to 
polysaccharides with a degree of polymerization (DP) of 750 or more,(12, 13) while enzymatic treatment 
releases mostly shorter chain oligosaccharides.(14) Additionally, autohydrolysis can release arabinoxylan 
structures that are resistant to enzymatic hydrolysis, as evidenced by increased yields with autohydrolysis 
(ca. 50% from maize bran and wheat bran) (12, 13) compared to enzymatic release (ca. 30% in wheat 
bran(10, 14) and <3% in maize bran (15)). 
Although the fermentation properties of AXOS have been reported extensively,(11) utilization of 
the soluble, non-digestible, feruloylated oligo- and polysaccharides (FOPS) released by autohydrolytic 
processing have only been studied in a few instances, and in these cases, the hydrolytic product was further 
treated with xylanase.(16-18) Because maize bran and wheat bran contain vastly different arabinoxylan 
structures(4, 6, 7) and the parent arabinoxylans from these two sources have been shown to be used very 
differently by gut bacteria,(8) the objectives of this study were to (1) determine treatment temperatures for 
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production of FOPS from maize bran and wheat bran and (2) determine the fermentation properties of 
partially purified FOPS from these substrates. 
3. Materials and Methods 
3.1. Safety 
The high-pressure processing followed the safety portions of the instrument manual (4848, Parr 
Instrument Co., Moline, IL). The chemicals used in this study required no special safety considerations. 
3.2. Production of FOPS 
  Maize bran was obtained from Bunge Milling (Crete, NE), and wheat bran was obtained from 
Horizon Mills (Newton, KS) and milled with a cyclone sample mill (UDY, Boulder, CA) equipped with a 1 
mm screen. A total of 150 g of milled bran and 1350 mL of water were combined in a 2 L high-pressure 
reactor (model 4848, Parr, Moline, IL). The slurry was heated to 170, 180, 190, or 200 °C at full power (ca. 
4 °C/min) under constant stirring at a speed of 400 rpm. The slurry was then cooled to 80 °C using an 
internal serpentine cold water cooling coil (ca. 15 min). Following the treatment, the slurries were 
centrifuged at 10000g for 10 min and the supernatant was retained. The supernatant was referred to as the 
autohydrolysate liquor (Figure 1). Each treatment was performed in duplicate. 
Total carbohydrate, total starch, free monosaccharides, free and esterified ferulic acid, furfural, 
hydroxymethylfurfural (HMF), total starch, and protein were determined in all autohydrolysate liquors (see 
Compositional Analyses). FOPS were calculated according to the following equation: 
FOPS (%)=Wara+Wxyl+Wman+Wgal+Wglc +Wfa 
where Wara is total arabinan (%), Wxyl is total xylan (%), Wman is total mannan (%), Wgal is total 
galactan (%), Wglc is total non-starch glucan (%), determined as the difference between the total glucan 
content after acid hydrolysis and the starch content, and Wfa is total esterified ferulate. Autohydrolysate 
liquors corresponding to treatment temperatures that resulted in the highest release of FOPS were also 
analyzed for molecular weight distribution and antioxidant activity (see Compositional Analyses). 
The autohydrolysate liquors from treatment temperatures corresponding to the highest release of 
FOPS were pooled and dialyzed (molecular weight cut-off of 500, Spectrum Laboratories, Rancho 
Dominguez, CA). The retentate was mixed with ion-exchange resin (AG501-X8, Bio-Rad, Hercules, CA) 
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at a rate of 1 g/20 mL and stirred gently overnight. After ion-exchange resin was removed by filtration, the 
sample was treated under partial vacuum at 80 °C to concentrate the solids and remove volatile compounds. 
The material, referred to as partially purified FOPS, was then freeze-dried and assayed for total 
carbohydrate, free monosaccharides, free ferulic acid and esterified ferulate, furfural, HMF, starch, protein, 
antioxidant activity, and molecular weight distribution (see Compositional Analyses). 
3.3. Fermentation of FOPS   
To prepare for fermentation, in vitro digestion of partially purified FOPS was performed according 
to Yang et al.(19) The digested content was dialyzed (molecular weight cut-off of 500). Dialyzed material 
was freeze-dried and analyzed for total carbohydrate, free monosaccharides, free ferulic acid and esterified 
ferulate, starch, furfural, HMF, protein, antioxidant activity, and molecular weight distribution (see 
Compositional Analyses). This material was referred to as digested FOPS. 
In vitro fermentation of digested FOPS was performed according to Hartzell et al.,(20) except that 
the sample size was 70 mg of carbohydrate instead of 100 mg. Fructooligosaccharides (FOS, Beneo, Morris 
Plains, NJ) were included as a positive control, and tubes containing no substrate were used as blanks. 
Samples (1 mL each) were taken at predetermined time points and stored at −80 °C. At times 0, 12, and 24 
h, samples were assayed for short-chain fatty acids (SCFA), Bifidobacterium, and antioxidant activity (see 
Fermentation Analysis and Compositional Analyses). At other time points, samples were only assayed for 
SCFA. 
3.4. Compositional analyses 
Dietary fiber content in maize brain and wheat bran were determined with AACCI method. (21) 
Total carbohydrate and free monosaccharides were determined according to Rose et al.(13) Briefly, 1 mL 
of liquid sample or 30 mg of solid sample were analyzed in tandem for carbohydrate content with or 
without chemical hydrolysis.(21) With hydrolysis constituted total carbohydrate, and without hydrolysis 
gave free monosaccharides. Oligo- and polymeric carbohydrates were determined as the differences 
between total carbohydrate and free monosaccharides. 
Free ferulic acid and esterified ferulate were measured using methods described by Yuan et al. (22) 
and Carole et al.(23) For bran samples, 10 mg of sample was weighed into a tube. If the sample was a 
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liquid (such as autohydrolysate liquors), 0.2 mL of sample was used. If sample was a freeze-dried powder, 
it was dissolved in water at 3% (w/v) and 0.2 mL of sample was used. Two tubes were prepared for 
analysis per replicate. To one of the tubes, which represented the total ferulic acid content, 0.2 mL of 0.4 M 
sodium hydroxide was added. The tube was shaken for 2 h at room temperature, and then 0.3 mL of 0.4 M 
phosphoric acid was added, followed by 0.2 mL of water. Free ferulic acid was assayed in the other tube in 
the same manner, except that sodium hydroxide was replaced by water. Each tube was then extracted with 
1 mL of ethyl acetate 3 times. The pooled ethyl acetate extracts were evaporated using a partial vacuum, 
and the extract was dissolved in 2 mL of 50% aqueous methanol. Samples were filtered through a 0.45 μm 
membrane, and 15 μL was injected into a high-performance liquid chromatograph (HPLC, 1260, Agilent, 
Santa Clara, CA) equipped with a C18 column (C-18-4E, Skowa Denko K.K., Tokyo, Japan) and 
ultraviolet (UV) detector at 320 nm. Elution was performed using the gradient described by Carole et al.(23) 
Quantification was by means of external calibration with a ferulic acid standard (MP Biomedicals, Solon, 
OH). Esterified ferulate content was calculated by the difference between the total ferulic acid and the free 
ferulic acid. 
Samples were analyzed for furfural and HMF by means of external calibration with authentic 
standards (Sigma-Aldrich, St. Louis, MO) following Gomis et al., (24) except that the mobile phase was 
96:4 (v/v) water/acetonitrile rather than 92:8. If the sample was a liquid, it was analyzed directly or after 
appropriate dilution (in samples containing high furfural or HMF concentration). If the sample was a 
freeze-dried powder, it was dissolved in water at 3% (w/v) for analysis. 
Total starch was measured in solid samples using a kit (K-TSTA, Megazyme, Bray, Ireland). In 
liquid samples, the total starch content was measured following the method from Rose et al.(12) The 
protein content of solid samples was obtained by a FP528 nitrogen/protein determinator (LECO 
Corporation, St. Joseph, MI) after using a conversion factor of 6.25 for percent nitrogen to percent 
protein.(25) In liquid samples, the protein content was measured using the Bradford method with bovine 
serum albumin (Pierco, Rockford, IL) used to create a standard curve.(26) 
To determine the molecular weight distribution, 10 mg of freeze-dried powder was dissolved in 2 
mL of water. Samples were filtered through a 0.45 μm membrane, and 100 μL was injected into a HPLC 
(Agilent) equipped with Shodex SB-G, SB-804 HQ, and SB-802 HQ (Skowa Denko K.K., Tokyo, Japan) 
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columns connected in series followed by a refractive index detector (Agilent). The mobile phase was 
aqueous 0.02% sodium azide at 0.5 mL/min. Molecular weight calibration was accomplished by means of 
external pullulan (P-82, Shodex) and glucooligosaccharide (4-7265, Sigma-Aldrich, St. Louis, MO) 
standards. 
Antioxidant activity was determined using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,2-
azino-bis-3-ethylbenzthiazoline-6-sulfonic acid (ATBS) methods. The DPPH assay was performed by 
reacting 0.2 mL of appropriately diluted sample with 1 mL of DPPH as described by Sensoy et al.,(27) 
except that, after incubating for 30 min, the tubes were centrifuged for 10 min at 3000g to remove the 
cloudiness. The ATBS assay was conducted according to Re et al.(28) Antioxidant activity was expressed 
relative to the antioxidant activity of 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox, 
Sigma-Adrich, St. Louis, MO). 
3.5. Fermentation analysis 
Samples taken during fermentation were thawed and centrifuged (10000g for 5 min). The 
supernatant was used for analysis of SCFA after Hartzell et al. (20) and for antioxidant activity (see 
Compositional Analyses). The pellet was used for analysis of Bifidobacterium by quantitative real-time 
polymerase chain reaction (PCR) as described.(20) 
4. Statistical analysis 
 For autohydrolytic processing, two replications at each temperature were performed. Each 
replicate was analyzed twice. Differences in chemical compositions were analyzed using analysis of 
variation (ANOVA) in combination with Fisher‘s protected least significant difference. The replicates from 
autohydrolysis were pooled for the in vitro fermentation stage. Differences in SCFA production between 
treatments were analyzed with three replicates using ANOVA with repeated measures followed by Fisher‘s 
protected least significant difference using SAS (version 9.2, SAS Institute, Cary, NC). Differences among 
substrate treatment on the population of Bifidobacterium and antioxidant activity were computed using 
ANOVA in combination with Fisher‘s protected least significant difference. 
5. Results and discussion 
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5.1. Production of FOPS 
Maize bran and wheat bran contained high concentrations of total dietary fiber (Table 1), most of 
which was water-insoluble.(29) Higher ferulic acid content was observed in maize bran compared to wheat 
bran. Maize has the highest ferulic acid content among major cereal brans, which exhibits high antioxidant 
activity and displays potential health benefits.(29) 
The composition of the autohydrolysate liquors differed depending upon the treatment temperature 
(Figure 2A). The release of FOPS was increased in autohydrolysate liquor from maize bran as the 
temperature increased from 170 to 190 °C and then showed a marked decrease from 190 to 200 °C. The 
highest yield represented 49% of the starting non-starch polysaccharide content and 44% of the initial 
ferulic acid content. With wheat bran, an increased final temperature resulted in a steady increase in the 
concentration of FOPS in the autohydrolysate liquor, ultimately releasing 50% of the initial non-starch 
polysaccharide content and 82% of the ferulic acid content at a final treatment temperature of 200 °C. 
These yields agree well with the percentage of cell-wall polysaccharides released by hydrothermal 
treatment of other agricultural byproducts (30) and were substantially higher than the AXOS released by 
enzymatic hydrolysis.(14) Thus, 190 and 200 °C were selected as the desirable temperatures to release 
FOPS from maize bran and wheat bran, respectively. 
The autohydrolysate liquors also contained high concentrations of non-FOPS material (Figure 2B). 
The release of arabinose and xylose was largely affected by the treatment temperature, with more arabinose 
being released (mainly side chain) than xylose (mainly backbone), suggesting that arabinoxylan was 
partially debranched during autohydrolysis (data not shown). Furfural and HMF increased as the treatment 
temperature increased. These compounds are one of the thermal degradation compounds of pentoses and 
hexoses, respectively. (31) Starch and protein were also present in autohydrolysate liquors (10.9–15.3 and 
0.180–2.01 g/L, respectively), but the concentration did not vary as a function of the treatment temperature. 
Dialysis, ion-exchange, and vacuum concentration were used to partially remove non-FOPS material from 
autohydrolysate liquors. The partially purified material from maize bran contained a higher percentage of 
FOPS compared to wheat bran (49 versus 30%, respectively; see Table 2). Nearly 4-fold higher antioxidant 
activity was observed on partially purified maize FOPS compared to wheat when using the ATBS radical; 
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when using the DPPH radical, maize FOPS showed 2-fold higher antioxidant activity compared to wheat 
(Table 2). 
The purification process removed furfural, HMF, and free ferulic acid (i.e., these compounds were 
not detectable in the partially purified samples; Table 2). More than 90% of the free monosaccharaides 
present in autohydrolysate liquors from both maize bran and wheat bran were removed with the partial 
purification process (Table 2). 
Because the purification process only concentrated oligo- and polysaccharides and removed non-
carbohydrate material, there was still substantial starch contamination in the partially purified FOPS 
preparations (15.5 and 27.1% in maize bran and wheat bran freeze-dried material, respectively; Table 2). 
Pretreatments are often employed to remove starch prior to producing FOPS-like materials.(12, 13) 
However, this step was not performed to simplify the production process because it was anticipated that the 
digestion phase would remove any contaminating starch prior to determining fermentation characteristics. 
Partially purified FOPS showed a broad molecular weight distribution, resulting from the 
fragmentation of arabinoxylan caused by high-pressure hydrothermal treatment. The majority of polymers 
ranged from 0.24 × 10
5
 to 1.9 × 10
5
 g/mol (Figure 3). The presence of high-molecular-weight polymers 
could have been due to the release of polysaccharides or from the release of oligosaccharides that were 
covalently linked through diferuloyl groups. 
5.2. Fermentation of FOPS 
Because the partially purified FOPS contained appreciable starch (Table 2), prior to in vitro 
fermentation, in vitro digestion was performed. In vitro digestion removed nearly all of the starch and, 
consequently, increased the percentage of FOPS in the freeze-dried material compared to the partially 
purified FOPS (Table 2). The digestion process also resulted in concentrating the ferulate content and, 
subsequently, increasing the antioxidant activity except for wheat bran with DPPH (Table 2). Protein 
decreased after digestion, but a small percentage persisted (2.37 and 3.27% in maize bran and wheat bran 
samples, respectively). Some of this protein could have been denatured enzymes from the digestion process 
as well as enzyme-resistant protein from the starting material. The difficulty in completely removing 
protein from cereal grain materials has been noted previously. (32) 
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In vitro digestion removed some of the shortest polymers in wheat FOPS (Figure 3), suggesting 
that starch may have been fragmented into small dextrins. However, the digested FOPS contained a similar 
broad molecular weight distribution compared to before in vitro digestion. 
In vitro fermentation was performed to determine how FOPS from maize bran and wheat bran 
were metabolized by fecal bacteria. Wheat FOPS resulted in lower SCFA production at 4 h compared to 
FOS (included as a positive control), and there was no significant change in SCFA production after 4 h 
(Table 3). Maize FOPS also showed low SCFA production relative to FOS at 4 h but brought about 
continual production of SCFA thereafter, resulting in the highest SCFA production at the end of the 
fermentation. 
 The steadily increasing fermentation profile of maize FOPS suggests that fermentation may persist 
into the distal part of the colon, where protein fermentation otherwise predominates, resulting in the 
production of toxic compounds, such as ammonia, phenol, indoles, thiols, amines, and sulfides. (34) A 
greater increase in SCFA production in the distal colon may result in protective effects by lowering the pH 
and inhibiting the fermentation of protein.(33) 
The difference in chemical structure between maize and wheat arabinoxylan may be responsible 
for their different fermentation profiles. As mentioned, maize arabinoxylan contains higher branch density 
and complexity, coupled with higher levels of esterified ferulic acid compared to wheat arabinoxylan.(4, 6, 
7) Notably, extended fermentation properties for alkali-extracted maize arabinoxylan(8) as well as its 
hydrolysate (34) have been shown previously. Thus, slow fermentation appears to be an inherent property 
of maize arabinoxylan, independent of the DP or method of release from the cell-wall matrix. 
Individual SCFA production also differed among substrates. After 24 h of fermentation, microbial 
butyrate production on maize FOPS was significantly higher than that on other substrates (Table 3). 
Butyrate has been shown to inhibit inflammatory responses by inhibiting activation of nuclear factor κB.(35) 
Thus, the high butyrate production of maize FOPS may exert potential health benefits compared to the 
other substrates.(33, 35, 36) Significantly higher propionate was also observed on maize FOPS compared to 
wheat FOPS. Propionate may reduce serum lipid as well as the risk of cardiovascular diseases. (37) 
Propionate has also been shown to have the potential to prevent obesity-related inflammation and 
associated diseases. (38) 
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Because the target of many prebiotic studies is to increase Bifidobacterium,(33, 39) and because 
AXOS produced by enzyme treatment have been shown to be particularly bifidogenic,(40-42) the shift in 
Bifidobacterium upon FOPS treatment was investigated. Both maize and wheat FOPS showed a significant 
increase in Bifidobacterium compared to the blank and baseline after 12 and 24 h of fermentation, although 
the increase was not as great as FOS (except for wheat FOPS after 12 h of fermentation; Figure 4). Wheat 
FOPS exhibited higher bifidogenicity than maize at the end of the fermentation. 
 These results are contrary to previous reports demonstrating that AXOS can be a more potent 
bifidogenic substrate than FOS. (40, 41) This is likely because FOPS (released by autohydrolysis) 
contained more complex, higher DP structures compared to AXOS (released by enzyme).(14) The higher 
branch density and complexity of maize arabinoxylan compared to wheat may account for the lower 
bifidogenicity of maize FOPS, whereas other bacteria may have greater capacity to use these substrates. For 
instance, the SCFA data suggest that maize FOPS supported butyrate producers (Table 3). The main 
butyrate producers in the gut include Eubacterium rectale/Roseburia spp. and Faecalibacterium prausnitzii, 
which have shown beneficial effects on the gut. (43) Other members of the gut microbiota also contribute 
to the SCFA pool. 
Although the gut is an anaerobic environment, the gut epithelia release reactive oxygen species 
into the lumen of the gut in response to environmental stresses and, in some cases, even commensal 
bacteria.(44) Numerous diseases, such as inflammatory bowel diseases and colon cancer, are associated 
with an imbalance in the gut cellular redox system.(45) When the antioxidant activity in the medium was 
measured, the potential ability of FOPS to prevent oxidative damage in the gut was investigated. 
As expected, because of the high ferulate content, at 0 h, the highest antioxidant activity was 
observed on maize FOPS (Figure 5). During fermentation, antioxidant activities changed depending upon 
the substrate and radical used for the antioxidant assay. On ATBS, the blank and FOS showed decreasing 
antioxidant activity as fermentation time progressed. The decrease was delayed when wheat FOPS was 
used, and maize FOPS showed an increase at 12 h before a decrease was experienced. In contrast to ATBS, 
radical scavenging ability against DPPH increased in all samples, including the blank and FOS, from 0 to 
12 h of fermentation, followed by a significant decrease in all samples, except maize FOPS at 24 h. 
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 The human microbiota can express several enzymes that are capable of releasing and metabolizing 
ferulic acid, (46, 47) the major antioxidant in FOPS. This has a dramatic effect on biological activity. (46-
50) First, gut bacteria probably hydrolyze the ester linkage and release free ferulic acid. (51) This would 
likely increase the antioxidant activity because free ferulic acid possesses higher antioxidant activity than 
esterified ferulate.(52) Upon release of the ferulic acid, modification of functional groups by microbial 
enzymes could further affect the antioxidant activity. Metabolism of ferulic acid first involves 
hydrogenation of the propen-2-oic acid side chain and demethylation of the ring ether (46) to form 3,4-
dihydroxyphenylpropionic acid.(46) This compound has been shown to possess higher antioxidant activity 
than ferulic acid in edible oil systems;(53) however, this compound is only transient and, subsequently, 
dehydroxylated to 3-hydroxyphenylpropionic acid and, finally, phenylpropionic acid.(46) These 
conversions likely decrease antioxidant activity. 
Other factors not directly related to the bioconversion of ferulic acid may also contribute to 
changes in antioxidant activity. For instance, higher antioxidant activity has been observed for free ferulic 
acid in the presence of AXOS compared to absence AXOS. (52) As mentioned, ferulic acid is initially de-
esterified by the gut microbiota, and this could be analogous to free ferulic acid in the presence of AXOS. 
As fermentation progresses, however, AXOS are removed from the system by microbial metabolism. 
Microbial metabolism of AXOS also leads to production of SCFA, which lower the pH and could affect 
antioxidant activity. (54) 
This study identified a high-pressure hydrothermal treatment of cereal bran that resulted in 
fragmentation of the cell wall. Final temperatures of 190 °C for maize bran and 200 °C for wheat bran 
resulted in the highest release of FOPS (49 and 50% of initial non-starch polysaccharide, respectively) and 
esterified ferulic acid (44 and 82% of initial ferulic acid, respectively). Maize FOPS displayed a desirable 
protracted fermentation profile with higher butyrate production compared to wheat FOPS and FOS. Both 
maize and wheat FOPS exhibited bifidogenic activity, although weaker than FOS. Maize FOPS exhibited 
high antioxidant capacity during fermentation that could have beneficial properties in vivo. Because FOPS 
can possibly combine beneficial fermentation properties and antioxidant activities, it may have potential to 
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Table 1. Selected composition of corn and wheat bran (% dry basis)
a
 
Component Corn bran Wheat bran 
Starch 10.6±0.2 14.4±0.3 
Total dietary fiber 64.6±1.4 47.2±1.4 
Arabinan 12.5±0.5 9.8±0.2 
Xylan 24.7±1.6 13.9±1.0 
Mannan 0.772±0.060 0.691±0.000 
Galactan 2.82±0.03 0.440±0.020 
Glucan 16.2±1.7 12.1±1.9 
Uronic acid 3.23±0.04 0.988±0.031 
Klason lignin 4.38±0.11 9.25±0.11 
Ferulic acid 2.51± 0.05 0.150 ±0.011 
Protein 5.33±0.01 17.1±0.0 
Other (by difference) 17.0 21.2 
a







Table 2. Composition of freeze-dried partially purified FOPS and digested FOPS from corn bran and wheat bran.
a
 
 Corn bran 
 
Wheat bran 
Component Partially purified FOPS Digested FOPS 
 
Partially purified FOPS Digested FOPS 


























Mannan (%) 0.16±0.18 0.34±0.03 
 
0.13±0.08 0.41±0.03* 



















      















Mannose (%) 0.13±0.03 trace* 
 
0.13±0.04 trace* 










      







Free ferulic acid (%) ND ND 
 
ND ND 





Furfural (%) ND ND 
 
ND ND 




     















Values are reported as mean (dry basis) ± SD (n=2); feruloylated oligo- and polysaccharides (FOPS) is the sum of arabinan, xylan, mannan, galactan, glucan, 
and esterified ferulate; hydroxymethylfurfural (HMF) ; ND = not detected.;*significantly different from partially purified FOPS of the same bran type; 







Table 3. Short chain fatty acid (SCFA) production (μmol/100mg initial carbohydrate) during in vitro fermentation of blank, fructooligosaccharides (FOS), and 
feruloylated oligo- and polysaccharides (FOPS) from corn bran and wheat bran.
a
 
Metabolite/ Fermentation time (h) 
Sample 4 8 12 24 
Acetate 
    Blank 213±18c 198±21b 203±31c 300±23c 
Corn FOPS 370±26b 541±52*a 530±40a 886±173*a 
Wheat FOPS 433±20b 472±75a 485±45a 454±29b 
FOS 560±30a 517±74a 495±98a 563±30b 
Propionate 
    Blank 45.5±5.2d 61.6±6.0c 62.8±7.1c 85.2±8.7*b 
Corn FOPS 71.7±6.7c 106±11*ab 111±11b 179±34*a 
Wheat FOPS 95.4±3.8b 90.8±10.9b 100±9b 91±6b 
FOS 137±10a 121 ±14a 155±19*a 164±9a 
Butyrate 
    Blank 58±6d 57.0±3.2c 52.7±15.4c 77.3±3.4*c 
Corn FOPS 104±7c 146±8*b 181±13*b 244±6*a 
Wheat FOPS 150±5b 182±15*a 209±9*a 206±10b 
FOS 181±19a 183±16*a 207±17*a 216±6*b 
Total SCFA 
    Blank 316±26e 317±28b 318±52b 462±31d 
Corn FOPS 546±26cd 795±74*a 822±43a 1040±218*a 
Wheat FOPS 679±32bc 745±100a 794±58a 751±30c 
FOS 878±46a 821±82a 715±131a 943±131*b 
 aValues are reported as mean± SD of  3 replicates; units are μmol/100mg initial carbohydrate; means followed by different letters with each column and SCFA 









Figure 1. Flowchart of the protocol, which consisted of two objectives: (1) production of FOPS and (2) fermentation of FOPS. (∗) Compositional analysis was 








Figure 2. Composition of autohydrolysate liquor upon hydrothermal treatment to selected temperatures: (A) FOPS and (B) non-FOPS material released by 









Figure. 3. Size-exclusion chroamtographs of  feruloylated oligo- and polysaccharides (FOPS); figures on left are partially purified FOPS; figures on right are 
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Figure 4. Enumeration of Bifidobacterium during in vitro fermentation. The baseline represents Bifidobacterium in the fecal inoculum before fermentation (0 h). 
The control represents a sample after fermentation with no added carbohydrate substrate. FOPS = feruloylated oligo- and polysaccharides. FOS = 
fructooligosaccharides. Bars marked with different letters are significantly different within each time point. (∗) Significantly different from the baseline (p < 








Figure 5. Antioxidant activity of fermentation medium before and after 12 and 24 h in vitro fermentation. The blank represents a sample after fermentation with 
no added carbohydrate substrate. FOPS = feruloylated oligo- and polysaccharides. FOS = fructooligosaccharides. Bars marked with different letters are 
significantly different within each time point. (∗) Significantly different from the corresponding substrates at the previous time point (p < 0.05). n = 3. Error bars 




Chapter 3 . Disparate metabolic responses in mice fed a high-fat diet supplemented with maize-
derived non-digestible feruloylated oligo- and polysaccharides are linked to changes in the gut 
microbiota 
1. Abstract 
Scope: Recent studies have suggested a positive link between colonic fermentation of dietary fibers and 
reduced incidence or severity of metabolic disorders. The objective of this study was to determine if 
consumption of a particular maize-derived dietary fiber—non-digestible feruloylated oligo- and 
polysaccharides (FOPS)—could counteract the deleterious effects of high-fat (HF) feeding and modulate 
the gut microbiota in mice.  
Methods and results: C57BL/6J mice (n=8/group) were fed a low-fat (LF; 10 kcal% fat), HF (62 kcal% 
fat), or HF diet supplemented with FOPS (5%, w/w). Four FOPS-fed mice (F-FOPS) showed enlarged ceca 
with enhanced short chain fatty acid (SCFA) production accompanied by significant improvements in 
glucose metabolism and plasma resistin compared with HF-fed mice. The remaining four FOPS-fed mice 
showed normal cecal fermentation with no metabolic improvements. Three F-FOPS mice showed increases 
in Blautia and Akkermansia and reduction in plasma leptin accompanied by reductions in body and adipose 
tissue weights compared with the HF-mice.  
Conclusions: FOPS could be an important promoter of SCFA production and shifts in the gut microbiota 
that could lead to reduction in metabolic disorders. However, more research aimed at identifying the cause 
of the disparate metabolic responses to dietary FOPS is warranted. 
2. Introduction 
Obesity is associated with a cluster of metabolic disorders including insulin resistance, type-2 
diabetes, and fatty liver disease [1]. These diseases diminish the quality of life of a growing proportion of 
the world‘s population, and there is an urgent need for strategies to reduce the prevalence of these diseases.  
The human gut microbiota exerts substantial effects on its host‘s metabolic and immune functions; 
abnormalities in its composition are associated with many diseases, including obesity, diabetes, heart 
disease, and some types of cancer [2-6]. One of the most promising means of manipulating ratios of species 




special class of dietary fibers that are preferentially fermented by select species of beneficial bacteria in the 
gut [7]. The selective increase in favorable bacteria as a result of prebiotic intake may benefit the host by 
precluding growth of detrimental bacteria through competitive inhibition, production of antibacterial 
compounds, metabolism of harmful substances, strengthening of gut barrier function, and synthesis of short 
chain fatty acids (SCFA) [7]. SCFA themselves may also benefit the host by improving glucose 
homeostasis, blood lipid profiles, and reducing body weight and colon cancer risk [8]. Thus the combined 
effects of prebiotics would likely contribute to long-term prevention of chronic subclinical inflammation 
that can develop into metabolic syndrome [9-12].   
In a previous study, we identified a hydrothermal process to produce non-digestible feruloylated 
oligo- and polysaccharides (FOPS) [13]. FOPS are composed of hydrolysates of the hemicellulosic 
component of maize bran, which is principally a complex heteroxylan comprised of a (1, 4)-linked β-D-
xylopyranosyl backbone with single or multi-unit branches consisting of α-L-arabinofruanose, β-D-
xylopyranose, β-D-glucuronic acid, and a non-carbohydrate antioxidant, ferulic acid [14]. The multi-unit 
branches in maize heteroxylan are rare among cereal dietary fibers, as are some of the linkages between 
sugars on these branches [e.g., (1, 2)- and (1, 3)-linkages between β-D-xylopyranose and α-L-
arabinofruanose]. Our previous in vitro data using human fecal microbiota has shown that this complex 
structure is more difficult for the microbiota to ferment than the hemicellulosic components of other cereals 
and thus may contribute to sustained SCFA production [13, 15]. Dietary fibers that are capable of 
supporting prolonged saccharolytic bacterial fermentation may help in maintaining beneficial SCFA 
production in the distal colon, which is low in SCFA and particularly prone to disease [16-18]. Our in vitro 
studies have also shown enhanced SCFA production of FOPS from maize bran, especially butyrate, 
compared with fructans and FOPS produced from wheat bran. Additionally, because of the high ferulic acid 
content, fermented FOPS samples contained high antioxidant activity. Antioxidants in the gut have been 
shown to reduce the damaging effects of free radicals such as nitric oxide that are released in the colon as a 
result of inflammation [19, 20]. Because of these promising in vitro results, the objective of this study was 
to determine if consumption of FOPS could counteract the deleterious effects of high-fat (HF) feeding and 
modulate the gut microbiota in mice.   




3.1. Production and composition of FOPS 
FOPS from maize bran was produced as described [13]. In brief, 150 g of finely milled maize bran 
(Bunge Milling, Crete, NE) was dispersed in 1.35 L of water in a 2 L high-pressure reactor (Model 4848, 
Parr, Moline, IL). The slurry was heated to 190 °C at the rate of 4 °C/min under constant stirring (400 rpm), 
and then was cooled to 80 °C using an internal serpentine coil with circulating cold water (ca. 15 min). The 
slurry was then centrifuged at 10, 000 × g for 10 min and the supernatant was retained. Supernatants from a 
total of ~25 batches were pooled and loaded into a reverse osmosis system (Model R, GEA Filtration, 
Hudson, WI, USA) equipped with a membrane (molecular weight cut off: 1000; GE 1207106, GEA 
Process Engineering Inc., Hudson, WI, USA). The FOPS were circulated with ~75 L of distilled water to 
separate contaminants (permeate) from FOPS (retentate). Following reverse osmosis, FOPS were freeze-
dried (Thermal-Vac Technology Inc., Orange, CA, USA). The freeze-dried material was subsequently 
analyzed for total carbohydrate, total starch, free monosaccharides, free and esterified ferulic acid, furfural, 
hydroxymethylfurfural (HMF), and protein as described [13]. FOPS was calculated as the sum of all non-
starch polymeric sugars and esterified ferulate [13]. The final FOPS preparation contained 59% FOPS, 16% 
starch, 3.4% other sugars, 2.9% protein, and 8.8% moisture (Table 1). 
3.2. Experimental diets and mouse experiment 
The three diets used in the study were prepared by a commercial provider (Research Diets, New 
Brunswick, NJ USA): low fat [LF; rodent diet with 10 kcal% fat (no sucrose); D12450K), HF (rodent diet 
with 62% kcal% fat; D12492), and HF supplemented with 5% FOPS (w/w; Table 2). FOPS were 
incorporated into the HF diet at the expense of cellulose. Because the FOPS preparation contained small 
quantities of starch and protein, the amounts of these compounds in the HF diet formulation were reduced 
to the extent necessary to match the macronutrient content of the HF control diet. The LF diet was included 
to confirm metabolic aberrations induced by the HF diet.  
Twenty four 8-week old male C57BL/6J mice were purchased from Jackson Lab (Bar Harbor, 
Maine USA). The animals were maintained in an environment with a 14 h light/10h dark cycle and 
controlled temperature and humidity. The mice were randomly assigned to one of the three dietary 
treatments (n=8 mice/group). Mice were housed in individually ventilated cages in pairs for a total of 4 




mice were acclimated to the cages for 1 week while consuming a regular autoclaved chow diet before 
starting the intervention. The dietary intervention continued for 8 weeks. Diet replacement and recording of 
food intake was performed every 2 weeks and the body weights were recorded every week.  
Feces were collected three times during the experiment (weeks 0, 1, and 8) and stored at -80°C 
until further analysis. After 8 weeks of experimental diet feeding, the mice were euthanized via CO2 
asphyxiation. Blood was harvested by cardiac puncture and plasma was collected by centrifugation at 
13,000 × g for 3 min at 4 °C. The liver, adipose tissue [visceral adipose tissue (VAT), epididymal adipose 
tissue (EAT), and subcutaneous adipose tissue (SAT)], and cecal tissue and contents were carefully 
removed and weighed. All biological samples were snap frozen in liquid nitrogen and then stored at -80 ˚C 
until analysis. The Institutional Animal Care and Use Committee at the University of Nebraska-Lincoln 
approved all procedures involving animals. 
3.3. Intraperitoneal glucose tolerance test 
Intraperitoneal glucose tolerance test (IPGTT) was carried out at 7 weeks. Food was removed 6 h 
prior to the test. Thirty minutes prior to the test, blood was collected from the tail vein to measure fasting 
glucose concentration using a glucose meter (ACCU-CHEK, Aviva Plus system, Indianapolis, IN, USA). 
An aliquot of blood was also saved for subsequent insulin analysis by ELISA (Mercodia Insulin ELISA Kit, 
Uppsala Sweden). At time zero, glucose solution (20 g/100 mL) was injected into the peritoneal cavity (1 g 
glucose/kg body weight) [21]. Blood glucose was measured 0, 15, 30, 60, 90 and 120 min after glucose 
injection. The homeostatic model assessment of insulin resistance (HOMA-IR), an indicator of insulin 
resistance [22], was calculated using the fasting insulin and blood glucose concentration as: HOMA-IR = 
[glucose (mg/dL)*insulin (μU/mL)]/405 [23]. 
3.4. Plasma lipids, cytokines, and hormones 
Plasma amylin, C-peptide, leptin, monocyte chemoattractant protein-1, interleukin 6, tumor 
necrosis factor-alpha, glucagon, peptide YY, pancreatic polypeptide, gastric inhibitory polypeptide, and 
ghrelin were measured by a multiplex immunoassay (Mouse Metabolic Magnetic Bead Panel Kit; Merck 




enzymatic reaction coupled to spectrophotometry detection (Infinity TG/Cholesterol kit; Thermo Electron, 
Waltham, MA, USA). 
3.5. Cecal short and branch chain fatty acids 
SCFA, acetate, propionate, and butyrate, and branch chain fatty acids (BCFA), iso-butyrate and 
iso-valerate, were quantified in the cecal contents collected at necropsy by GC [24].Quantification was 
done by means of internal calibration with 2-ethyl butyric acid. 
3.6. Characterization of the fecal microbiota composition 
DNA was extracted through mechanical and enzymatic cell lysis as previously described [25]. 
Microbial composition was assessed at weeks 0, 1, and 8 by 16S rRNA gene sequencing (MiSeq; Illumina; 
San Diego, CA, USA) [26] targeting the V5-V6 region with primer pair 784F (5‘-RGGATTAGATACCC-
3‘) and 1064R (5‘-CGACRRCCATGCANCACCT-3‘). Initial quality filtering and demultiplexing of the 
resulting reads was performed with Illumina Software. Next, reads were merged with the merge-Illumina-
pairs application, which also removed primers and performed further quality check of the sequences [27]. 
Subsequently, the UPARSE pipeline [28] was used to process the sequences and perform operational 
taxonomic unit (OTU) clustering, using a 98% similarity cutoff. Sequences were independently subjected 
to taxonomic classification for phylum to genus characterization of the fecal microbiome using the RDP 
MultiClassifier 1.1 from the Ribosomal Database Project [29]. Taxonomic bins were computed as 
proportions based on the total number of sequences in each sample. α-Diversity were calculated using 
QIIME [30]. 
3.7. Statistical analysis 
We divided the mice on the FOPS diet into those with enlarged ceca that fermented the FOPS (F-
FOPS) and those with ceca of normal size (N-FOPS) (Result 4.1). Results are presented as mean ± SEM or 
SD, as indicated in figure or table captions, with the exception of results shown in Fig. 6 and 
Supplementary Fig. 1, where results are shown as individual observations. The impact of dietary treatments 
on body mass, metabolic markers, and gut microbiota α-diversity were analyzed using one-factor ANOVA 
(diet). Body weight and blood glucose during the IPGTT were analyzed using two-factor repeated measures 




hoc test with comparisons (HF vs. LF; HF vs. N-FOPS; HF vs. F-FOPS; N-FOPS vs. F-FOPS). Differences 
in individual fecal microbiota OTUs between N-FOPS and F-FOPS groups were assessed using t-tests for 
each of the three weeks that fecal pellets were collected. Principal components analysis (PCA) of fecal 
microbiota OTU abundances were also computed. Correlations between bacterial groups and host 
physiological measurements in the HF- and FOPS-fed mice were calculated using Pearson's coefficients. 
Microbial taxa <1% in abundance in sum in all mice at all-time points were excluded from the analyses. P 
< 0.05 was used to consider all statistical significance. All data were analyzed using SAS software (version 
9.4; SAS Institute, Cary, NC, USA) with the exception of PCA, which was performed using XLSTAT 
software (Statistical Innovations, Belmont, MA USA).   
4. Results 
4.1. Allocation of mice in the FOPS group into fermenters and non-fermenters 
During necropsy we observed dramatic cecal enlargement in four mice in the FOPS group, while 
the other four mice and all of the mice in the other treatment groups contained ceca of normal size (Fig. 1). 
This did not appear to be a cage effect; two of the mice with enlarged ceca were from the same cage, while 
the other two mice shared cages with mice that had ceca of normal size. No significant differences in cecal 
SCFA or BCFA pools were evident among LF, HF, and N-FOPS (Fig. 2). However, total SCFA pool was 
significantly elevated in the mice with enlarged ceca compared with the other groups (Fig. 2A, 2C-E). 
These mice showed marked increases in acetate and propionate pools. Butyrate production was also 
elevated in this group, but with wide variation among mice. A significant increase in BCFA production was 
detected in the mice with enlarged ceca compared with others (Fig. 2B); however, the BCFA/SCFA ratio 
was significantly lower than other groups (Fig. 2F), suggesting that the elevated BCFA production was a 
result of greater overall fermentative activity and not a tendency toward putrefactive fermentation as is 
often the case with elevated BCFA production. Given that higher cecal weight and SCFA pool was an 
indication of increased fermentation and metabolic activity of the gut microbiota [31], we divided the mice 
on the FOPS diet into those with enlarged ceca that fermented the FOPS (F-FOPS), and those with ceca of 
normal size (N-FOPS) for subsequent data analysis and presentation.  




There was no difference in feed intake between the HF and FOPS groups (Fig. 3); however, there 
were differences in body weight gain among treatment groups (Fig. 4A). The F-FOPS group gained weight 
at a slower rate during the 8-week study such that at the end of the study the F-FOPS mice exhibited a 
significant reduction in body weight gain compared with the HF-fed control mice (Fig. 4B). F-FOPS mice 
also exhibited a significant reduction in epididymal, subcutaneous, and visceral adipose tissue weights 
compared with the HF-fed control mice (Fig. 4C-E). Remarkably, within the F-FOPS group three mice (6, 
7, and 8) consistently showed adipose tissue weights that were similar to the LF-fed mice, while one mouse 
(3) consistently showed weights similar to the N-FOPS mice and the HF group. In contrast to F-FOPS mice, 
body weight gain and adipose tissue weights of the N-FOPS mice during the 8 week study mirrored the 
HF-fed control mice. 
4.3. Influence of FOPS on blood glucose and insulin  
HF feeding resulted in increased fasting bood glucose, fasting insulin, and HOMA-IR, 
accompanied by impaired glucose tolerance compared with LF feeding (Fig. 5), indicating metabolic 
aberrations related to impaired glucose tolerance in the HF-fed mice. The F-FOPS group showed 
significant decreases in fasting insulin accompanied by a 79% reduction in HOMA-IR compared with the 
HF-fed mice. Unlike body weight and adipose tissue data, mouse 3 did not stand out from the other FOPS 
mice but instead showed similar glycemic and insulinemic profiles to mice 6, 7, and 8 in the F-FOPS group.   
4.4. Influence of FOPS on plasma hormones and lipids 
HF feeding resulted in increased C-peptide and amylin compared with HF-fed mice (Fig. 6A and 
6B), in concordance with the insulin data from the IPGTT. Among the markers analyzed in the multiplex 
assay, only resistin and leptin showed significant differences between HF and LF and were thus associated 
with metabolic disorder. There was a significant decrease in leptin in F-FOPS compared with HF and N-
FOPS and a significant decrease in resistin in F-FOPS compared with HF (Fig. 6C and 6D). Mouse 3 in the 
F-FOPS group showed separation from mice 6, 7, and 8 for leptin but not for resistin. HF-fed mice showed 
significantly elevated plasma cholesterol and triacylglycerol concentrations compared with LF-fed mice; 
however, FOPS did not result in any improvements in these lipids (Fig. 7).  




α-Diversity of the fecal microbiota significantly decreased over time for all treatment groups, and 
the decrease was especially pronounced in the F-FOPS group (Fig. 8A). PCA based on OTU abundance 
showed no clustering by treatment group at baseline (Fig. 8B), whereas principle component 1 separated 
FOPS from HF and LF at week 1 (Fig. 8C), which persisted after 8 weeks (Fig. 8D). F-FOPS mice 6, 7, and 
8 clustered separately from the other mice, while F-FOPS mouse 3 clustered with N-FOPS mice.  
At week 0, all mice had similar microbial composition dominated by the Lachnospiraceae family 
(Fig. 9). The most remarkable change in microbiota composition over the course of the study was the 
substantial increase in OTUs belonging to the Blautia and Akkermansia genera in F-FOPS mice at week 8. 
Combined, these 2 OTUs represented approximately 80% of the fecal microbiota in F-FOPS mice 6, 7, and 
8. Notably these are the same three mice that clustered together on the PCA plots (Fig. 8B-D), and explain 
the substantial decrease in α-diversity in these mice. In contrast, mouse 3, which was also in the F-FOPS 
group as it had an enlarged cecum, did not show elevated Blautia and Akkermansia. Interestingly, at week 0 
all mice had very low abundance of Blautia (<1%), and, while abundance of this genus remained low in the 
LF and HF-fed mice (<0.01%), during the course of the study it increased in all FOPS-fed mice (<0.01% at 
week 0; 7.5% at week 1; 17.5% at week 8). 
Differences in fecal microbiota proportions between N-FOPS and F-FOPS at each time point were 
calculated. At week 0, the F-FOPS mice had significantly higher proportions of OTUs 8 (Peptococcaceae) 
and 33 (Acetivibrio) compared with N-FOPS, while N-FOPS mice had a significantly higher abundance of 
OTU 34 (a member of Lachnospiraceae family) compared with F-FOPS (Fig. 10). At week 1, N-FOPS 
mice had significantly higher abundances of two OTUs belonging to the Lachnospiraceae family (OTU 7 
and OTU 13) compared with F-FOPS mice. At week 8, F-FOPS mice had significantly higher proportions 
of OTU 1 (Akkermansia) and OTU 9 (Blautia), while N-FOPS mice had significantly higher proportions of 
two OTUs belonging to the Lachnospiraceae family (7 and 13). 
4.6. Correlation of microbial composition with host metabolic markers 
Body weight gain, leptin, and the weight of EAT and SAT were negatively correlated with 
Akkermansia, Blautia and OTU 89 (a member of the Ruminococcaceae family; Fig. 11); plasma cholesterol 
was also negatively correlated with Akkermansia. There were positive correlations between SCFA 




(both members of the Lachnospiraceae family) were positively correlated with negative outcomes: body 
weight gain, fasting glucose, C-peptide, amylin, plasma cholesterol, leptin, resistin, and the weight of EAT 
and SAT. 
5. Discussion 
In this study, we investigated how FOPS affected body and tissue weights, markers of metabolic 
syndrome, and gut microbiota composition in C57BL/6J mice fed a HF diet. We observed disparate 
metabolic responses to the FOPS diet intervention. Enhanced cecal fermentation with associated metabolic 
improvements was evident in some mice (F-FOPS), while other mice showed normal cecal fermentation 
and no metabolic improvements compared with mice in the HF group (N-FOPS).  
The F-FOPS group showed greater insulin sensitivity and lower fasting flood glucose compared 
with the HF-fed mice. These improvements in glucose homeostasis in the F-FOPS mice might be due to 
enhanced SCFA production from the FOPS fermentation. The mice in the F-FOPS group displayed 
substantial increases in cecal propionate production accompanied by decreased plasma resistin. Propionate 
has been associated with a reduction in the expression of resistin, a pro-inflammatory factor in adipose 
tissue [32]. Decreased resistin has been shown to improve glucose tolerance and insulin sensitivity in obese 
mice by enhancing insulin-mediated glucose disposal in muscle and adipose tissue [33]. Taken together, 
these factors may constitute a possible mechanism of the improvements in glucose metabolism in the F-
FOPS mice.  
F-FOPS mice also showed significant reduction in body weight gain compared with HF-fed mice. 
However, the mechanism responsible for weight gain reduction appears to be different from that 
responsible for improvements in glucose tolerance.  The overall fecal microbiota structure of F-FOPS mice 
6, 7, and 8, which displayed the greatest improvements in body weight gain, adipose weights, and leptin, 
clustered together and were dominated by Akkermansia and Blautia. In contrast, this increase in 
Akkermansia and Blautia was not evident in F-FOPS mouse 3, and this mouse also did not show 
improvements in any of the body or adipose tissue measurements or leptin, suggesting that these two 
bacterial groups may be involved in these specific improvements. Recent studies have demonstrated an 
inverse association between Akkermansia and Blautia and markers of obesity-related metabolic disorders 




concomitant reduction in fat mass gain and adipose tissue inflammation [37]. Akkermansia may affect host 
metabolism through the enhancement of gut barrier function or production of endocannabinoids that control 
inflammation [38]. In the case of Blautia, diet-induced obesity has been shown to strongly reduce the 
abundance of this genus in mice [39].  Another study suggested that the prevention of obesity and insulin 
resistance in HF-fed rats by berberine, a yellow pigment found in some plant tissues, may be partially 
mediated by Blautia [40]. Additionally, given that obesity can be linked to leptin resistance and that leptin 
is primarily involved in energy expenditure [41], the significant decrease in plasma leptin (especially in 
mice 6, 7, and 8) in F-FOPS suggested enhanced leptin sensitivity in these mice, which might be 
responsible for the decreased weight gain [41]. Plasma leptin was also negatively correlated with 
Akkermansia and Blautia. These findings suggest the importance of Akkermansia and Blautia in the 
metabolic improvements related to weight reduction with FOPS. This is in contrast to other reports 
showing that the metabolic disorders associated with HF feeding in mice may be modulated by shifting the 
gut microbiota toward that of lean mice using dietary prebiotics or probiotics [42, 43]. This could be due to 
differences in the types of dietary interventions introduced among studies.  
It is unclear why the mice in the FOPS group responded so differently to the treatment. While the 
phenomenon of responders versus non-responders to prebiotic interventions has been described in human 
studies [44, 45], it is less common in inbred mouse studies (although not unheard of [46]). Once confirming 
that the differences in response to FOPS was not a cage effect, we hypothesized that the four mice in the F-
FOPS group may have had different gut microbiota profiles at baseline compared with the N-FOPS mice 
that enabled them to utilize the FOPS substrate. As mentioned, the FOPS contained unusual linkages, 
including (1, 2) and (1, 3)-linkages connecting branched chain xylose and arabinose, which may have 
required the presence of uncommon carbohydrate-active enzymes to initiate fermentation [47]. Bacteria 
capable of expressing such enzymes may allow for the fermentation of FOPS and subsequent changes in 
the microbiota by cross feeding. Diversity and PCA plots suggested that the overall community structures 
between N-FOPS and F-FOPS were similar; however, there were subtle differences that may have been 
meaningful. For instance, Acetivibrio cellulolyticus, which was elevated in the F-FOPS mice, can secrete an 




not detectable through 16S rRNA community profiling, may have existed between the FOPS-fed mice that 
exhibited an ability to ferment FOPS and those that did not. 
Other environmental factors might have also been involved, for instance the frequency and 
quantity of chow consumed by individual mice could have affected the fermentation patterns of FOPS, 
although cage 12, which had two F-FOPS, did not appear to have a marked abnormal feed consumption 
compared to the other cages.  Alternatively, mice parentage may be another factor; one study suggested that 
mouse siblings share similar microbiotas compared with non-siblings [49]. Perhaps F-FOPS mice were 
closely related and N-FOPS mice were closely related but different from F-FOPS. Further, differences in 
regulatory mechanisms, such as developmental epigenetic changes, which can dynamically respond to 
environmental and nutritional exposure [50], might also be a reason for the differences in response to FOPS. 
One interesting consideration is that the study duration may have not been long enough to observe 
a response to FOPS in all mice; it was only long enough to see it in some mice. We observed that all mice 
in the FOPS group (both N-FOPS and F-FOPS) had a noticeable abundance of Blautia after 1 week of the 
FOPS treatment, while none of the LF- or HF-fed mice did. This suggests that FOPS may select directly for 
Blautia. The bloom in Blautia may then create favorable conditions for the growth of Akkermansia by 
consuming hydrogen [51], a gas that inhibits the fermentation pathways used by Akkermansia for 
production of acetate and propionate [52, 53]. Extrapolating this line of reasoning, it may be that the bloom 
in Akkermansia might simply be delayed in some mice; should the experiment have extended for longer 
than the 8-week time frame we may have eventually seen a bloom in Akkermansia in all FOPS mice. 
Admittedly, this is speculative and we do not have an explanation as to why mice would differ so greatly in 
their temporal response to FOPS. However, in our present results, one mouse (6) showed the bloom in 
Blautia and Akkermansia very rapidly (after only 1 week), while the other two that showed this phenotype 
(7 and 8) took longer. 
Taken together, we observed heterogeneous metabolic adaptation of mice to a FOPS intervention. 
Although we cannot provide an explanation for the different responses to FOPS treatment, we conclude 
that the metabolic improvements related to glucose tolerance induced by FOPS in obese mice might be a 
consequence of colonic fermentation of FOPS and production of SCFA, while the metabolic improvements 




new evidence for modulating the gut microbiota through dietary fiber treatment and indicate its 
contribution to the improvement of host metabolism. 
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Total carbohydrate (%) 74.4 
FOPS (%) 59.1 
Arabinan (%) 10.13±0.19 
Xylan (%) 33.55±1.29 
Mannan (%) 0.30±0.00 
Galactan (%) 4.71±0.21 
Glucan (%) 4.44±0.56 
Esterified ferulate (%) 4.13±0.03 
       Uronic acid 1.88±0.08 
Free monosaccharides (%) 3.44±0.09 
Arabinose (%) 1.28±0.02 




Galactose (%) 0.53±0.01 
Glucose (%) 0.58±0.03 
Starch (%) 15.98±0.51 
Free ferulic acid (%) ND 
Protein (%) 2.62±0.05 




Moisture content (%) 8.77 
a
 Values are reported as mean± standard deviation (n=2); 
b
















  Casein 19.0 25.8 25.1 
L-Cystine 0.284 0.388 0.381 
Corn Starch 52.1 0 0 
Maltodextrin 10 14.2 16.2 14.4 
Sucrose 0 8.89 8.73 
Cellulose 4.742 6.46 1.32 
Crude FOPS
b
 0 0 8.51 
Lard 1.90 31.7 31.1 
Soybean Oil 2.37 3.2 3.17 
Mineral Mix S10026 0.948 1.29 1.27 
Dicalcium Phosphate 1.23 1.69 1.65 
Calcium Carbonate 0.521 0.711 0.698 
Potassium Citrate, 1 H2O 1.56 2.13 2.09 
Vitamin Mix V10001 0.948 1.292 1.27 
Choline Bitartrate 0.190 0.258 0.254 
Red Dye #40, FD&C 0.00237 0 0.00635 
Blue Dye #1, FD&C 0.00237 0.00646 0 
Weight% 
   Protein 19.2 23.1 22.7 
Carbohydrate 67.3 26.3 25.9 
FOPS 0 0 5 
Fat 4.30 35.2 34.6 
Fiber 4.70 6.50 6.30 
Crude FOPS 0 0 8.50 
kcal% 
   Protein 20 18 18 
Carbohydrate 70 20 20 
Fat 10 62 62 
Total 100 100 100 
kcal/gm 3.90 5.10 5.10 
a
 LF: low fat; HF: high fat diet; FOPS: high fat diet with FOPS; LF (D12450K) and HF formulation were 
based on D12492 from Research Diet. 
b 












Figure 1. Cecal weights of mice in each treatment group; mean ± SEM; n = 8 mice/group for LF, HF, and FOPS; n = 4 mice/group for N-FOPS and F-FOPS; 
mouse numbers are shown for FOPS mice to track individual mice across figures; *significantly different using Bonferroni‘s multiple comparison test with four 









Figure 2. Cecal SCFA (A), BCFA (B),  acetate (C), propionate (D), butyrate (E), and BCFA/SCFA ratio (F) of mice in each treatment group; mean ± SEM; n = 8 
mice/group for HF and LF; n = 4 mice/group for N-FOPS and F-FOPS; mouse numbers are shown for FOPS mice to track individual mice across figures; 





















Figure 4. Body weight (A),  body weight gain (B), and visceral (C), epididymal (D), and subcutaneous (E) adipose tissue weights at week 8 by treatment group;  
mean ± SEM; n = 8 mice/group for HF and LF; n = 4 mice/group for N-FOPS and F-FOPS; mouse numbers are shown for FOPS mice to track individual mice 
across figures; *significantly different using Bonferroni‘s multiple comparison test with four relevant comparisons: LF vs. HF; HF vs. N-FOPS; HF vs. F-FOPS; 










Figure 5. Fasting glycemia (A), fasting insulinemia (B), HOMA-IR (C), and glucose tolerance curve (D) at week 7 by treatment group; mean ± SEM; n = 8 
mice/group for HF and LF; n = 4 mice/group for N-FOPS and F-FOPS; mouse numbers are shown for FOPS mice to track individual mice across figures; 
*significantly different using Bonferroni‘s multiple comparison test with four relevant comparisons: LF vs. HF; HF vs. N-FOPS; HF vs. F-FOPS; F-FOPS vs. Y-









Figure 6. Plasma C-peptide (A), amylin (B), resistin (C), and leptin (D) in different treatment groups; mean ± SEM; n = 8 mice/group for HF and LF; n = 4 
mice/group for N-FOPS and F-FOPS; mouse numbers are shown for FOPS mice to track individual mice across figures; *significantly different using 










Figure 7. Plasma cholesterol (A) and triglycerides (B) in different treatment groups mean ± SEM; n = 8 mice/group for HF and LF; n = 4 mice/group for N-FOPS 
and F-FOPS; mouse numbers are shown for FOPS mice to track individual mice across figures.*significantly different using Bonferroni‘s multiple comparison 










Figure 8. α-Diversity of the fecal bacterial communities (A) and principal components analysis of the abundance of OTU (B-D) at weeks 0, 1, and 8; 
in (A) mean ± SEM; n = 8 mice/group for HF and LF; n = 4 mice/group for N-FOPS and F-FOPS; in (B-D) blue dots represent LF; the green dots 
represent HF; the red dots represent N-FOPS; the purple dots represent F-FOPS; mouse numbers are shown for FOPS mice to track individual 











Figure 9. Fecal microbiota composition based on OTU abundance in different mice at weeks 0, 1, and 8; mouse numbers are shown for FOPS mice to track 









Figure 10. Abundance of bacterial taxa between NFOPS and YFOPS that showed significant differences at week 0, week 1, and week 8. *Significantly different 
















Chapter 4 . Long-term dietary pattern of fecal donor correlates with butyrate production and 
markers of protein fermentation during in vitro fecal fermentation 
1. Abstract 
Diet influences gut microbiota composition. Therefore, we hypothesized that diet would impact 
the extent of dietary fiber utilization and the types of metabolic end-products produced by the microbiota 
during in vitro fecal fermentation. By obtaining long-term dietary records from fecal donors, we aimed to 
determine the correlations between dietary intake variables and dietary fiber degradation, short-/branched-
chain fatty acid (BCFA) production and ammonia production during in vitro fecal fermentation. Eighteen 
subjects completed 1-year diet history questionnaires and provided fecal samples that were used for in vitro 
fermentation of a whole wheat substrate. The percentage of dietary fiber fermented was not correlated with 
nutrient intakes; however, butyrate production was correlated with fecal donor intake of many nutrients of 
which principal component analysis revealed were mostly contributed by grain-, nut-, and vegetable-based 
foods. Negative correlations were found for propionate with intake of total carbohydrate, added sugar and 
sucrose, and for ammonia and BCFA production with intake of unsaturated fats. Thus, our analysis did not 
support our first hypothesis: the percentage of dietary fiber fermented during in vitro fermentation was not 
correlated with dietary records. However, production of butyrate; BCFA; ammonia; and, to a lesser extent, 
propionate was correlated with the diet records of fecal donors, thus supporting our second hypothesis. 
These results suggest that diets high in plant-based foods and high in unsaturated fats are associated with 







  The human gut is colonized by the gut microbiota, a complex and dynamic microbial community 
whose collective genome exceeds the size of the human genome by 2 orders of magnitude [1]. The gut 
microbiota is involved in host energy harvest and storage [2], immune response [3], and development of 
metabolic syndrome [4]. 
Previous reports have focused on how diet changes the gut microbiota composition [5], [6], 
[7] and [8]. One study found that the fecal microbiota from children in Burkina Faso consuming a diet high 
in dietary fiber contained an enrichment of Prevotella and Xylanibacter, which contain species that are 
evolved to efficiently use cellulose and xylans, compared with children in the European Union consuming 
more refined diets [5]. In another cross-sectional study, long-term intake of protein and animal fat led to 
enrichment in Bacteroides compared with long-term intake of carbohydrates, which is associated with 
Prevotella [8]. Controlled trials have shown that diet can rapidly alter the types of bacteria that appear in 
the feces. Russell et al [7] showed a decline in Roseburia/Eubacterium rectale when subjects were on a 
high-protein, low-carbohydrate diet compared with a maintenance diet. The susceptibility of these butyrate 
producers to carbohydrate intake was confirmed in subjects consuming diets devoid of carbohydrate [6]. 
Although knowledge on the compositional changes in the gut microbiota is of interest, the 
products of gut microbiota metabolism are of at least equivalent importance. For instance, short-chain fatty 
acids (SCFAs), the major metabolites produced by gut microbiota, have been suggested to be important 
regulators of energy balance, gut inflammation signaling, and insulin sensitivity [7]. Conversely, ammonia 
and branched-chain fatty acid (BCFA) productions have been implicated as having undesirable effects on 
host health [7] and [9]. 
Past approaches to quantify these metabolites have included analysis of fecal samples for the 
compounds themselves or for genes involved in their production [7], [10] and [11]. In addition, others have 
drawn conclusions about metabolite production based on the proportions of bacteria present [12] and [13]. 
However, given that these metabolites are absorbed and metabolized by the colonic epithelia cells, these 
approaches either do not reflect the actual production or are only semiquantitative [14] and [15]. 
When addressing changes in the gut microbiota in response to diet, a wealth of research has 





galactooligosaccharides) [16]. These prebiotics are highly fermentable by the gut microbiota and result in 
desirable shifts in gut microbiota composition. However, intake of these oligosaccharides in most diets (1-4 
g/d) [17] is dwarfed by the quantities of complex and poorly fermented dietary fibers (eg, cellulose, cross-
linked arabinoxylan, and complex pectic substances) that typically make up the substrates for gut bacteria 
(11-20 g/d) [18]. Although these dietary fibers are generally poorly fermented by gut bacteria, it could be 
that adequate and continuous dietary exposure of these materials to the gut microbiota would cause 
compositional shifts such that the microbiota are more able to use these substrates with subsequent benefits 
to the host [5]. 
Unfortunately, quantitative measures of fermentation of specific dietary fibers and resulting SCFA 
production by the gut microbiota in humans are not practical in vivo. Although conditions in in vitro batch 
fermentations are very different from conditions in the large intestine (eg, no absorption of metabolites, 
water, minerals, or other nutrients; no pH control [except buffering]; no mucus layer; etc), batch in vitro 
fecal fermentation models may be an ideal way to evaluate both the microbial production of certain 
metabolites, as well as utilization of complex substrates, because compounds are not absorbed and can 
easily be quantified [19]. Furthermore, in our previous study, we found that changes in the gut microbiota 
during 12 hours of  in vitro fermentation were similar to changes reported in the literature for human trials 
[20]. 
We hypothesized that diet of the fecal donor would impact the extent of dietary fiber utilization 
and the types of metabolic end-products produced by the microbiota during in vitro fecal fermentation. To 
test our hypothesis, we assessed long-term dietary patterns of subjects using a food frequency questionnaire 
(FFQ) and then used stool samples collected from these individuals as a source of bacteria for in vitro 
fermentation using predigested whole wheat flour as a substrate. We then quantified carbohydrate 
fermented, SCFA, BCFA, and ammonia produced during fermentation and correlated the results with 
intake of nutrients and food groups of the stool donors. This research may allow us to identify dietary 
strategies to alter the production of metabolites by the gut microbiota in a manner that is consistent with 
human health. 





3.1. Subjects, dietary records, and stool sample collection 
Individuals who were 19 years or older, considered themselves to be in generally good health with 
no digestive diseases or dietary restrictions (excluding voluntary dietary restrictions), and had not taken 
antibiotics in the last 6 months were recruited using electronic and paper advertisements on campus at 
University of Nebraska-Lincoln. Individuals who met these criteria were invited to participate in this study. 
Subjects completed the past-year (long-term) food intake diet history questionnaire (DHQ) II online [21]. 
The DHQ II is a validated FFQ consisting of 134 food items and 8 dietary supplement questions [22]. The 
survey included questions about seasonal differences in food intakes. Each subject received a unique login 
and password and completed the DHQ II after brief instructions on how to properly complete the 
questionnaire. Subjects' responses were analyzed using Diet*Calc software (Bethesda, MD, USA) [23]. 
This software used food frequency responses from subjects to estimate daily food intakes and serving sizes 
based on combined results from the National Health and Nutrition Examination Surveys (NHANES) 
conducted in 2001 to 2002, 2003 to 2004, and 2005 to 2006. Daily nutrient and food group intakes were 
generated using the DHQ Database [24], which computed nutrient estimates using data from the USDA 
Nutrient Database for Standard Reference [25] and the Nutrient Data System for Research [26]. The My 
Pyramid Equivalents Database [27] was used to calculate daily servings from various food groups. 
At the time subjects received their login and password information for the DHQ II, they received 
stool collection materials and instructions on how to use them. Subjects were instructed to bring a stool 
sample to the laboratory within 2 hours of defecation. The stool collection materials included a collection 
container with tight-fitting lid that fit under the toilet seat (Commode Specimen Collection System; Fisher 
Scientific, Pittsburgh, PA, USA), an insulated cooler with cold packs, and an anaerobic gas-generating 
tablet (Anaerocult C; BD GasPak, Franklin Lakes, NJ, USA), which subjects placed inside the collection 
container immediately after defecation and before securing the lid and packing in the cooler. Immediately 
upon receiving stool samples from subjects, study personnel transferred the sample to an anaerobic hood 
(Bactron X; Sheldon Manufacturing, Cornelius, OR, USA) where it was packaged into a specimen bag 
(Fisher). The packaged fecal sample was then stored at −80°C until analysis. 
All protocols involving human subjects were approved by the University of Nebraska-Lincoln's 





consent and were modestly compensated for their involvement in this study. Subjects received 
compensation for completing each of the 2 tasks separately (completion of DHQ II and stool sample 
donation); they were not coerced into completing both tasks. Thirty-one individuals completed the DHQ II, 
and of those 31 individuals, 24 also provided fecal samples. Four subjects were excluded from the study 
due to extreme reported energy intakes (<1300 kcal/d or >3500 kcal/d), and 2 subjects were excluded due 
to insufficient fecal sample for analysis. In total, 18 samples were used for in vitro fecal fermentation. 
3.2. Whole wheat substrate 
Hard red winter wheat (Triticum aestivum ―McGill‖) was obtained from Husker Genetics, the 
University of Nebraska-Lincoln's Foundation Seed Division. Wheat was milled with a cyclone sample mill 
equipped with a 1-mm screen (UDY Corporation, Fort Collins, CO, USA). 
The flour thus obtained was subjected to an in vitro digestion procedure as described [28]. Briefly, 
wheat flour (25 g) was mixed with 300 mL of water and boiled for 20 minutes with constant stirring. Upon 
cooling to room temperature, the pH was adjusted to 2.5 with 1 M HCl, and then 10 mL of 10% (wt/vol) 
pepsin (P-700; Sigma, St Louis, MO, USA) in 50 mM HCl was added. The mixture was placed on an 
orbital shaker (150 rpm) at 37°C for 30 minutes, whereupon 50 mL of 0.1 M sodium maleate buffer (pH 6, 
containing 1 mM CaCl2) was added and the pH was adjusted to 6.9 with 1 M NaHCO3. Fifty milliliters of 
12.5% (wt/vol) pancreatin (P-7545; Sigma) in sodium maleate buffer and 2 mL of amyloglucosidase (3260 
U/mL; Megazyme, Bray, Ireland) were then added, and samples were kept in a shaking water bath at 37°C 
for 6 hours. 
After digestion, the slurry was transferred to dialysis tubing (molecular weight cutoff, 12 000-14 
000) and dialyzed against distilled water for 4 days with a water change every 12 hours. The retentate was 
then freeze dried. The resulting material contained 2.16% ± 0.08% starch (mean ± SD, n = 3) and 63.1% ± 
0.8% total dietary fiber, as measured by a total starch kit (K-TSTA; Megazyme) and by approved method 
32-25 [29] with the following modifications: 5 μL of 2-octanol was added before the reduction step to 
minimize loss of ammonium hydroxide, and reduction time was increased from 60 to 90 minutes. 
3.3. In vitro fermentation 
In vitro fermentation of freeze-dried substrate with the fecal inocula was carried out following the 





freeze-dried material was suspended in 1-mL sterile fermentation medium consisting of (per liter) peptone 
(2 g, BP1420-100; Fisher Scientific), yeast extract (2 g, CAS8013-01-2; Alfa Aesar, Ward Hill, MA, USA), 
bile salts (0.5 g, LP0055; Oxoid, Hampshire, UK), NaHCO3 (2 g), NaCl (0.1 g), K2HPO4 (0.08 g), 
MgSO4.7H2O (0.01 g), CaCl2.6H2O (0.01 g), l-cysteine hydrochloride (0.5 g; Sigma), hemin (50 mg; 
Sigma), Tween 80 (2 mL), vitamin K (10 μL; Sigma), and 0.025% (wt/vol) resazurin solution (4 mL) and 
then hydrated overnight on ice. Tubes were then inoculated with 0.1 mL of fecal slurry, capped, and 
incubated at 37°C with shaking (140 rpm) for 12 hours. The fecal slurry was prepared by blending the fecal 
sample with sterile phosphate-buffered saline using a hand blender for 1 minute and then filtering through 4 
layers of cheesecloth. All steps for fermentation were conducted in an anaerobic hood (Bactron IV; 
Sheldon Manufacturing) containing 5% H2, 5% CO2, and 90% N2. Separate sample tubes were prepared for 
analysis of carbohydrates, ammonia, and SCFA/BCFA at time 0 and 12 hours of fermentation, and 
duplicate tubes were prepared for each analysis due to the insoluble nature of a portion of the whole wheat 
substrate. Thus, for each fecal sample, 12 sample tubes were fermented. At each designated time point, 
microbial metabolism was stopped according to different methods based on the analysis to be performed. In 
tubes designated for carbohydrates, microbial metabolism was terminated by adding 0.2 mL of 2 M H2SO4 
containing 10 mg myo-inositol per milliliter as an internal standard. In tubes designated for SCFA/BCFA, 
microbial metabolism was terminated by adding 0.2 mL of 2 M KOH containing 7 mM 2-ethyl-butyrate as 
an internal standard (the KOH also had the added benefit of preventing volatilization of the SCFA/BCFA). 
In tubes designated for ammonia, microbial metabolism was terminated by adding 0.2 mL 5.2 mM CuSO4. 
3.4. Fermentation analyses 
Samples for carbohydrate analysis were freeze dried, and the residue was subjected to the 
hydrolysis and derivatization steps using approved method 32-25 [29] with the modifications described 
above, as well as proportionate scaling down of reagents to match the smaller sample size. Total neutral 
polysaccharides were the sum of all sugar residues analyzed (arabinan, xylan, mannan, galactan, and 
glucan), arabinoxylan was the sum of arabinan and xylan, and cellulose was the sum of nonstarch glucan. 
Samples for SCFA/BCFA were thawed and centrifuged (10000g, 5 minutes). The supernatant was then 
used for analysis of SCFA after Hartzell et al [30]. In short, 0.5 mL of supernatant was mixed with 





then 0.4 mL of diethyl ether was added. Tubes were capped and inverted 20 times, and then 1 μL of the 
diethyl ether extract was injected onto a gas chromatograph (Clarus 580; PerkinElmer, Waltham, MA, USA) 
equipped with a capillary column (Elite-FFAP, 15 m × 0.25 mm inner diameter × 0.25 μm film thickness; 
PerkinElmer) and detected with a flame ionization detector. Short-chain fatty acid/BCFA was quantified by 
calculating response factors for each SCFA/BCFA relative to 2-ethyl butyric acid using injections of pure 
standards. 
Samples for ammonia analysis were centrifuged (8000g, 5 minutes), and the supernatant was 
assayed for ammonia using the phenol hypochlorite method [31]. In short, supernatants were diluted to less 
than 75 μM ammonia (1:100-1:300), and 1 mL of the diluted sample was mixed with 40 μL of phenol-
alcohol solution (1 mL liquefied phenol diluted to 10 mL with absolute ethanol), 40 μL of 0.2% (wt/vol) 
sodium nitroprusside, and 0.1 mL of freshly prepared oxidizing solution (prepared by combining 4 parts of 
20% trisodium citrate in 1% NaOH and 1 part of 13% sodium hypochlorite). After 1 hour, the absorbance 
was read at 650 nm. Quantification was accomplished by means of external calibration with solutions of 
ammonium chloride (0-75 μM). 
4. Statistical analysis 
All statistical analyses were performed using SAS software (version 9.4; SAS Institute, Cary, NC, 
USA). Data for carbohydrate fermentation and metabolite production were analyzed using 1-way analysis 
of variance with subject as the factor using the GLM procedure. For carbohydrate fermentation and 
metabolite production analysis of variance models with significant F values (P < .05), pairwise 
comparisons were calculated by the least significant difference procedure. Pearson correlations among 
percent carbohydrate fermented and microbial metabolites produced during fermentation were computed 
using the CORR procedure. For correlations of dietary intake of each fecal donor with metabolite 
production or carbohydrate degradation during in vitro fermentation, Spearman correlation coefficients 
were computed using mean values from each subject using the CORR procedure and correcting for age and 
sex. Correlations among dietary intake categories that carried significant correlations with butyrate 
production were also calculated. These data were also used for principal component analysis (PCA) using 
the PRINCOMP procedure with a rank transformation (generated using PRINQUAL). Correlations of each 





5. Results and discussion 
5.1. Subjects and dietary records 
Of the 18 subjects whose fecal samples were used in the in vitro fermentations, 11 were male and 
7 were female (Table 1).  Subject IDs were used to track the 18 individuals. The age range was from 20 to 
37 years with a mean age of 26.7 ± 5.4 years. Subjects ranged greatly in reported intake of nutrients and 
other compounds. As expected from NHANES data [18], intake of total fat, saturated fat, cholesterol, 
protein (of which most was animal protein), and sodium was generally above recommendations, whereas 
intake of total carbohydrate, dietary fiber, vitamin D, magnesium, and potassium was below 
recommendations. Subject 15 was noted for having low consumption of energy and fat, whereas subject 1 
was noted for the highest intake of many of the micronutrients. 
Intake of foods from specific categories was also typical of a US population (Table 2). Reported 
intakes of total and refined grain, dairy, and meat dominated the diets. Other common food categories 
included total vegetables, fruit, poultry, and nuts. 
5.2. Carbohydrate fermentation and metabolite production 
Disappearance of the principal dietary fibers in the whole wheat substrate over the 12 hours of in 
vitro fermentation was monitored (Fig. 1). Clearly, there was great variation in the ability of each fecal 
microbiota to use the substrate. The fecal microbiotas from subjects 13, 16, and 65 were among the least 
able to ferment the dietary fibers in wheat, whereas the fecal microbiotas from subjects 21, 27, and 98 used 
the most. The fecal microbiotas from subjects 1 and 27 were the most efficient at fermenting both 
arabinoxylan and cellulose. 
As with the carbohydrate fermentation data, SCFA production varied greatly (Fig. 2). Interestingly, 
however, SCFA production was not correlated with the amount of carbohydrate fermented in any instance 
(P values for correlations ranged from .08 [for cellulose fermentation vs acetate production] to .82). The 
fecal microbiota from subject 99 produced the most total SCFA, which was composed of mostly acetate 
and propionate; this microbiota was among the lowest in butyrate production. The fecal microbiota from 
subject 11 produced much more butyrate than any other microbiota. Several other fecal microbiotas, 
including those from subjects 1, 5, 16, 19, 25, 26, and 27, produced butyrate at concentrations ranging from 





Like the SCFA data, markers of protein fermentation did not correlate with the percentage of 
carbohydrate fermented (P values ranged from .49 to .97) but did show interesting variation among fecal 
microbiotas ( Fig. 3). The fecal microbiota from many subjects, including 1, 4, 5, 7, 11, 12, 24, 25, 65, and 
98, produced very low concentrations of BCFA during the fermentation period, whereas the fecal 
microbiota from other subjects, particularly that of subject 21, produced appreciable concentrations of 
BCFAs. Production of these metabolites was highly correlated with ammonia production (P = .0011, .0015, 
and .0009 for ammonia vs iso-butyrate, iso-valerate, and BCFA, respectively). We also performed the 
correlation analysis by sex, and the results showed most correlations found before were driven by men only 
(data not shown here). Thus, it would be an interesting area to investigate the difference response of gut 
microbiota from different sexes in the future. 
5.3. Correlation between dietary records and carbohydrate fermentation and metabolite production 
No correlations between the amount of carbohydrate fermented and intakes of any of the nutrients 
or other compounds analyzed were found (Fig. 4). However, correlation analysis for intake of nutrients and 
other compounds vs metabolite production during fermentation was quite interesting. Many significant 
positive correlations were discovered for butyrate production during fermentation. When correlations were 
analyzed by sex, most nutrients remained significant for men but not for women. Among the rest of the 
SCFA, significant negative correlations were noted for total carbohydrate, added sugar, and sucrose intakes 
vs propionate production. Branched-chain fatty acid and ammonia data showed significant negative 
correlations with fat intake, in particular, with unsaturated fat intake. 
A few correlations were noted for intake of certain food categories and carbohydrate fermented 
and metabolite production during fermentation (Fig. 5). Butyrate again carried the most significant 
correlations, including positive correlations with ―total vegetable,‖ ―potatoes,‖ ―other vegetables,‖ and ―fish 
high in omega-3s,‖ and a negative correlation with ―eggs.‖ ―Total grain,‖ ―whole grain,‖ and ―refined grain‖ 
intakes also tended to be correlated with butyrate (Spearman ρ = 0.43, 0.45, and 0.45; P = .10, .08, and .08, 
respectively). The relevance of some of these correlations is limited due to low reported intake (eg, 
potatoes, fish high in ω-3 fatty acids, ―soy products,‖ and ―dry beans and peas‖; Table S2) or poor range of 





The fecal microbiota from subjects that consumed diets high in whole grains did not appear to be 
particularly specialized in degrading the whole wheat substrate. For instance, subject 1 had the highest 
whole grain intake and subject 24 the lowest, whereas the percentage of arabinoxylan and neutral 
polysaccharides fermented between the 2 subjects was not significantly different. 
5.4. Principal component analysis of nutrients and other compounds that were correlated with 
butyrate production 
The nutrients and other compounds that were significantly correlated with butyrate were also 
significantly correlated with each other in most cases (Table S3). Thus, we desired to look at these nutrients 
as a whole, rather than individually. Therefore, we used PCA to condense these highly correlated nutrients 
and other compounds into fewer variables. With the exception of cholesterol, intake of all of these nutrients 
carried similar positive Eigenvectors on principal component 1 (0.65-0.95), which accounted for 70% of 
the variation in nutrient intake. Because principal component 1 explained so much of the variation in 
nutrient intake and was the only principal component that was significantly correlated with butyrate 
production (r = 0.65; P = .003), we used this principal component as a metric to identify foods that 
contributed to high intakes of these nutrients. Intake of total grain, refined grain, whole grain, ―nuts and 
seeds,‖ total vegetables, and ―other vegetables‖ were the greatest contributors to high intakes of nutrients 
that were significantly correlated with butyrate production during fermentation ( Fig. 6). 
6. Discussion 
 In this study, we hypothesized that (1) the long-term dietary pattern of the fecal donor would 
impact the extent to which the microbiota could use a particular substrate, which, in turn, would (2) impact 
SCFA, BCFA, and ammonia production during in vitro fecal fermentation. Our analysis did not support our 
first hypothesis: the percentage of dietary fiber fermented during in vitro fermentation was not correlated 
with dietary records. However, production of butyrate; BCFA; ammonia; and, to a lesser extent, propionate 
was correlated with the diet records of fecal donors, thus supporting our second hypothesis. This suggests 
that diet does not influence the extent to which dietary fiber is fermented, but rather the types of bacteria 
that ferment it (which led to the differences in metabolite production). 
More specifically, our study revealed 2 significant findings. First, butyrate production during in 





accompanied by a noticeable dearth of correlations with other SCFAs (except for a limited number with 
propionate), suggesting that butyrate production by gut bacteria is highly influenced by diet, with 
production of the other SCFA much less affected. The correlations with butyrate production are important 
because butyrate possesses anti-inflammatory properties [32]. Butyrate regulates host intestinal barrier 
function [33] and may prevent passage of lipopolysaccharide, a detrimental microbial metabolite, from the 
gut lumen into systemic circulation [15]. 
The nutrients and dietary compounds that were correlated with butyrate production clearly pointed 
to foods of plant origin. Correlations with all types of dietary fibers (total, soluble, and insoluble) 
demonstrated the dependence of butyrate producers on adequate dietary fiber consumption, a finding that is 
supported by clinical trials showing that butyrate producers are highly dependent on adequate dietary 
carbohydrate substrates [6] and [7]. Many other micronutrients were also correlated with butyrate 
production. Although a diet high in dietary fiber-containing foods would undoubtedly also be high in these 
micronutrients, which was noted by significant correlations among intakes of such nutrients, it is 
nevertheless interesting to consider the dependence of the gut microbiota not only on dietary fiber but also 
on dietary vitamins and minerals as well. Only a fraction of the vitamins and minerals consumed in the diet 
are absorbed in the small intestine [34]; therefore, many of these nutrients make their way to the large 
bowel where they influence the gut microbiota [35], [36], [37] and [38]. Because of the dense microbial 
community in this region, it is likely that these nutrients would be in high demand and the less adaptable 
bacteria would be more susceptible to lack of these compounds. Based on literature data, we might 
speculate that these vulnerable bacteria would be those bacteria that are considered beneficial, including 
bifidobacteria and the butyrate producers [6], [7] and [35]. 
Because butyrate was correlated with the intake of so many nutrients and other dietary compounds 
that were themselves correlated, we used PCA to determine the types of foods that contributed most to 
intake of these nutrients and other compounds. This approach revealed that intake of grains, nuts, and 
vegetables contributed most to intake of these compounds and thus might be important in maintaining 
butyrate production in the gut. This was consistent with our results from correlative analysis of butyrate 
production directly with reported intake of these food categories, although in the latter case, some of the 





The second notable finding was the strong negative correlation of ammonia and BCFA production 
with intake of unsaturated fats. Although dietary triacylglycerols are typically considered completely 
digestible, the specific fatty acid composition of the diet influences the gut microbiota [39], [40] and [41]. 
In particular, studies in mice have shown that, compared with unsaturated fats, saturated fats persist into the 
distal small intestine where they exhibited an antimicrobial effect [39]. This antimicrobial effect can lead to 
decreased proportions of beneficial bacteria and a decrease in microbial diversity (an undesirable outcome) 
[39] and [42]. Our study suggests that a diet high in unsaturated fat may lead to a gut microbiota that 
produces fewer undesirable fermentation products. 
Another notable finding was the negative correlation of propionate production with refined grains 
and added sugars. Typically, propionate is thought of as a beneficial SCFA [43] and [44]. However, our 
previous study showed that the fecal microbiota from obese individuals produces more propionate during in 
vitro fermentation of whole grains [28], and Schwiertz et al [10] reported higher propionate concentrations 
in feces of overweight and obese individuals. This was attributed to enrichment in Bacteroides, which are 
important propionate producers in the gut. Thus, the fecal microbiotas from subjects consuming diets high 
in refined grains and added sugars may have started out the fermentation with higher proportions of 
Bacteroides, which translated into higher propionate production during fermentation. 
It is interesting to consider why there was a lack of an association between the percentage of 
dietary fiber used during fermentation and intake of dietary fiber in the diet. It may be that the types of 
bacteria that are favored when dietary fiber intake is low are also able to adapt quickly to this new substrate 
upon exposure to it. For instance, several studies have shown that diets that are very low or devoid of 
dietary fiber-containing foods lead to a bloom in Bacteroides. Bacteroides possess more genes that encode 
for dietary fiber-degrading enzymes than other gut bacteria and thus may be quick to adjust to metabolizing 
the dietary fibers in whole grains even if they rarely saw these substrates in abundance previously. Notably, 
we did not assess fermentation rate. Thus, it could be that during the early stages of fermentation, there was 
a lag in the dietary fiber fermentation rate by the fecal microbiotas from subjects consuming low dietary 
fiber diets, but by the time 12 hours of fermentation had transpired, these microbial communities had 
adapted to the whole wheat substrate such that the percentages of dietary fibers fermented were similar to 





It is well known that different types of dietary fiber impart different physiological effects [20]. For 
this study, we used whole wheat as the substrate. However, another substrate, such as fructans, resistant 
starch, or even dietary fibers isolated from vegetables or fruit, may produce different correlations with 
nutrient intake of the fecal donor with different implications than those reported herein. 
We recognize that there were several limitations to this study. The major limitation was the use of an FFQ 
to assess dietary intake. This approach carried with it the limitations inherent in FFQs, such as differences 
in how accurately subjects answer the questions and how well the database used to calculate nutrient 
intakes reflects true nutrient intake [45]. Thus, reported dietary data may not quantitatively reflect actual 
intakes. Other FFQs or other methods of collecting food intake data, such as 24-hour recalls, may yield 
different intake results. In addition, some subjects may have had dietary practices that were not covered by 
the questionnaire, such as use of probiotics. Furthermore, overweight subjects have been reported to 
underestimate food intakes [46], which was not considered in this study. Another limitation was our small 
sample size. At the outset of the study, calculation of an appropriate sample size was difficult because there 
were no previous studies on how diet impacts the performance of the fecal microbiota in an in vitro model 
system. With a samples size of 18 and 2 covariates (age and sex), we were able to detect correlation 
coefficients of 0.64 with α = .05 and β = .2. We anticipated that this would be an appropriate, if not small, 
sample size because similar correlations have been reported between dietary records and gut microbial taxa 
[8] and because correlations smaller than 0.64, although possibly statistically significant, may not be 
practically significant due to wide variation among individuals or limited physiological impact of the 
relationship. Finally, our findings are only correlative and do not imply causation. With these limitations 
acknowledged, we nevertheless felt that our study design was a reasonable approach to assess the possible 
relationships between human diet and metabolite production by the gut microbiota, which could serve as 
valuable information in the design of mechanistic studies and clinical trials on improving human health 
through interactions of diet with the gut microbiome. 
Our study has shown that long-term intake of plant-based nutrients, particularly those from grains, 
nuts, and vegetables, is correlated with butyrate production during in vitro fermentation of a whole wheat 
substrate, whereas high intakes of unsaturated fats are associated with fewer markers of protein 





production of metabolites by the gut microbiota even when exposed to identical substrates. Future studies 
should determine if changes to dietary patterns can alter metabolite production during in vitro fermentation. 
This could result in new dietary strategies for improving the metabolism of the gut microbiota in a manner 
that is consistent with host health. 
Supplementary data to this article can be found in Table 1, 2, and 3. 
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Table 3. Spearman correlations among nutrients that were significantly corrrelated with butyrate production during in vitro  fermentation. 

















Figure 1. Carbohydrate fermentation during 12 h of in vitro fecal fermentation; error bars show standard deviation; bars marked with different letters are 










Figure 2. Short chain fatty acid (SCFA) production during 12 h of in vitro fecal fermentation; error bars show standard deviation; bars marked with different 









Figure 3. Branched chain fatty acid (BCFA) and ammonia production during 12 h of in vitro fecal fermentation; error bars show standard deviation; bars marked 










Figure 4. Spearman ρ correlation of dietary nutrient intake of the fecal donor with carbohydrate fermented (%) and metabolite production (mM) during in vitro 
fecal fermentation; bars indicate the direction (left, negative; right, positive) and magnitude of the correlation; gray bars indicate non-significant correlations; 










Figure 5. Spearman ρ correlation of food category intake of the fecal donor with carbohydrate fermented (%) and metabolite production (mM) during in vitro 
fecal fermentation; bars indicate the direction (left, negative; right, positive) and magnitude of the correlation; gray bars indicate non-significant correlations; 










Figure 6. Eigenvectors on principal component 1 (PC1) for each nutrient or other dietary compound that was significantly correlated with butyrate production (A) 





Chapter 5 . Impact of pre-digested whole grain wheat flour on the composition and metabolites of the 
gut microbiota using in vitro fecal fermentation 
1. Abstract 
 Our previous study has identified an approach of in vitro fermentation to assess the functionality 
of the microbiome that is not demonstrated by analyzing fecal SCFA. The study suggested that long-term 
diets high in plant-based foods and high in unsaturated fat are associated with the production of gut 
microbiota metabolites that are consistent with host heath after in vitro fermentation of predigested whole 
wheat flour. However, little is known about the influence of long-term dietary pattern and the fermentation 
of whole grain wheat on the gut microbiota composition. Thus, the objective of the study was to investigate 
the impacts of long-term dietary pattern on gut microbiota composition and to investigate the change in 
composition of the gut microbiota during fermentation of predigested whole wheat flour. Eighteen subjects 
provided fecal samples that were used for in vitro fermentation of predigested whole wheat flour. We did 
not observe significantly positive correlations between specific gut microbiota taxa and the nutrients that 
have been shown to be associated with the function of the gut microbiota from our previous study (chapter 
4). Butyrate production was significantly correlated with the abundance of Butyricicoccus, Coprococcus, 
Dorea, Faecalibacterium, and Lachnospiracea incertae sedis. Branched chain fatty acids (BCFA) and 
ammonia production displayed negative correlations with the abundance of Roseburia and Parasutterella. 
Bifidobacterium, an indicator for gut health, and Butyricicoccus, a butyrate producer, were enhanced by 






Diet is considered a major driver for changes in the gut microbiota composition. Long-term intake 
of protein and animal fat resulted in the enrichment in Bacteroides compared with long-term intake of 
carbohydrates, which lead to the increase in Prevotella [1]. Diets high in dietary fiber lead to an enrichment 
of Prevotella and Xylanibacter, compared with a more refined diet [2].  
Other than the composition, the function of the gut microbiota is of equal importance. The gut 
microbiota can affect the host by either producing the harmful metabolites associated with human diseases 
or beneficial components that protect against diseases, depending on the dietary intake. The gut microbiota 
can produce harmful ammonia and amines through proteolytic fermentation [3], while production of short 
chain fatty acids (SCFA) from carbohydrate fermentation may have health benefits [4, 5]. Particularly, 
butyrate, which is a preferred energy source of gut epithelial cells, has been shown to promote energy 
expenditure and improve insulin sensitivity [6]. The investigation of the function of the gut microbiota is 
difficult to perform in vivo. For instance, quantitative measures of fermentation of specific dietary fibers 
and resulting SCFA production by the gut microbiota in humans are not practical in vivo. In vitro fecal 
fermentation models may be an ideal way to evaluate the function of the gut microbiota, such as microbial 
production of certain metabolites as well as utilization of complex substrates because compounds are not 
absorbed and can easily be quantified. Our previous study has suggested that long-term dietary pattern 
affected the function of the gut microbitoa using the in vitro model [7]. 
To date, a vast amount of research has focused on impacts of prebiotics, particularly inulin-type 
fructans on the gut microbiota (3). However, even if one consumes a very healthy diet, intake of traditional 
prebiotics would still be low. In contrast, whole grain wheat is the major dietary fiber source in the US diet 
and accounts for a large portion of the fiber that reaches the colonic site. Whole grain wheat flours are rich 
sources of dietary fiber and phytochemicals including phenolics, minerals, carotenoids, vitamin E, lignans, 
and phytates (4). A diet high in whole grain wheat has been shown to improve metabolic disorders through 
modulating the gut microbiota (5).  
Our previous study identified an approach of in vitro fermentation to assess the functionality of the 
microbiome that is not demonstrated by analyzing fecal SCFA, and suggested that long-term diets high in 





metabolites that are consistent with host health after in vitro fermentation of predigested whole wheat flour 
[7]. However, little is known about the influence of long-term dietary pattern and the fermentation of whole 
grain wheat on the gut microbiota composition. Thus, the first objective of the study was to investigate the 
impacts of long-term dietary pattern on gut microbiota composition. The second objective was to 
investigate the change in composition of the gut microbiota during fermentation of predigested whole 
wheat flour.  
3. Methods 
3.1. Subjects, dietary records, and stool sample collection 
Eighteen subjects of 19 years of age or older with no history of digestive diseases and no 
antibiotics consumption in the last 6 months were recruited to participate in this study. The long-term 
dietary records of each subject were collected by completing the past-year (long-term) food intake diet 
history questionnaire II (DHQ II) online described by Yang et al. [7] 
Subjects were instructed to bring a stool sample to the laboratory within 2 h of defecation. The 
stool collection materials included a collection container (Commode Specimen Collection System; Fisher 
Scientific, Pittsburgh, PA, USA), an insulated cooler with cold packs, and an anaerobic gas-generating 
tablet (Anaerocult C; BD GasPak, Franklin Lakes, NJ, USA), which subjects placed inside the collection 
container immediately after defecation and before securing the lid and packing in the cooler. Immediately 
after receiving stool samples, study personnel transferred the sample to an anaerobic hood (Bactron X; 
Sheldon Manufacturing, Cornelius, OR, USA) where the stool sample was packaged into a specimen bag 
(Fisher). The packaged fecal sample was then stored at -80 °C for future analysis. All protocols were 
approved by the University of Nebraska-Lincoln's Institutional Review Board before initiation of the study 
(no. 20120512624EP). 
3.2. In vitro digestion and fermentation 
Hard red winter wheat (Triticum aestivum ―McGill‖) was obtained from Husker Genetics, the 
University of Nebraska-Lincoln's Foundation Seed Division. Wheat was milled through a cyclone sample 
mill equipped with a 1 mm screen (UDY Corporation, Fort Collins, CO, USA). The whole grain wheat 





freeze-dried (Labconco, Kansas City, MO, USA). The freeze-dried material were then subjected to in vitro 
fermentation using stool samples collected from 18 individuals as described [7].  
3.3. Fermentation analyses 
 Microbial composition was assessed at baseline and after 12 h of in vitro fermentation. One 
milliliter of slurry was thawed and the cells were recovered by centrifugation (10,000 g for 5 min at room 
temperature). DNA was then extracted from the pellet with the phenol/chloroform method as described [8]. 
Microbial proportions were then assessed using 16S rRNA sequencing (MiSeq; Illumina; San Diego, CA 
USA) [9]. First, PCR-enrichment of the V5-V6 region of the 16S rRNA gene was done with primer pair 
784F (5‘-RGGATTAGATACCC-3‘) and 1064R (5‘-CGACRRCCATGCANCACCT-3‘). This was 
followed by PCR tailing to attach adaptors and barcodes. Next, samples were individually quantified and 
their concentrations normalized. The samples were pooled and the PCR products size selected with 
AMPureXP beads (Beckman Coulter). The final pool was again quantified and normalized to 2 nM for 
input into Illumina MiSeq (v3 Kit) to produce 2x300 bp sequencing products.  Clustering was done at 10 
pM with a 5% spike of PhiX. Initial quality filtering of the reads was performed with the Illumina Software. 
Next, reads were merged with the merge-Illumina-pairs application, which removed primers and performed 
further quality check of the sequences [10]. Subsequently, the UPARSE pipeline [11] was used to process 
the sequences and perform operational taxonomic unit (OTU) clustering. Sequences were independently 
subjected to taxonomic classification for phylum to genus characterization of the fecal microbiome using 
the RDP MultiClassifier 1.1 from the Ribosomal Database Project [12]. Phylotypes were computed as 
proportions based on the total number of sequences in each sample. α-Diversity (observed species) and β-
diversity were calculated using tools implemented in QIIME [13] . 
Carbohydrate content of the pre-digested whole wheat flour before and after in vitro fermentation, 
as well as SCFA, branched chain fatty acids, and ammonia generation during in vitro fermentation of these 
samples were reported previously [7].  
3.4. Statistical analysis 
 Principal component analysis (PCA) based on OTU abundance was computed using XLSTAT 





and after in vitro fermentation were analyzed using paired t-test. Pearson‘s correlations between fecal gut 
microbiota composition and dietary nutrients were computed using SAS software (version 9.4; SAS 
Institute, Cary, NC, USA). Pearson‘s correlations between gut microbiota composition and their 
metabolites after in vitro fermentation were computed using SAS software. Only microbial taxa at the 
genus level were included and microbial taxa with abundance <1% were excluded from the analyses. P < 
0.05 was used to consider all statistical significance. 
4. Results 
4.1. Influence of long-term dietary pattern on the fecal gut microbiota composition 
Significant correlations between stool donor nutrient intakes and gut microbiota compositions are 
shown in Fig. 1. Butyricicoccus exhibited significantly positive correlation with PUFA, Vitamin A and E., 
while exhibited significantly negative correlation with fructose.  Erysipelotrichaceae_incertae_sedis 
exhibited significantly positive correlation with trans fat, carbohydrate, sugars, fructose, and starch.  
Our previous research has suggested significant positive correlations between several plant-based 
nutrients (carbohydrate, starch, dietary fiber, soluble fiber, insoluble fiber, plant protein, thiamin, riboflavin, 
niacin, pantothenic acid, vitamin B-6, folate, Cu, Fe, Mg, Zn, betaine, and phytic acid) and the function of 
the gut microbiota using an in vitro model [7]. However, we did not observe significantly positive 
correlations between these nutrients and specific gut microbiota taxa.  
4.2. Influence of digested whole wheat flour on the composition of gut microbiota 
The stool microbial communities and the microbial communities after in vitro fermentation of 
digested whole wheat flour were clearly differentiated on PC1, with the fermented samples showing a 
negative shift along this axis (Fig. 2A). The shift of the gut microbiota community on the PCA plot was 
driven by the change in several specific OTUs. The OTUs with significant loadings on this PC were 
identified (Fig. 2B). The loadings of individual OTUs on PC1 revealed that 4 taxa belonging to 
Bifidobacterium, Bacteroidetes, Anaerovora, and Escherichia were primarily responsible for a negative 
shift on this axis.  
Significant changes in the gut microbiota at the genus level during fermentation are shown in Fig. 





Butyricicoccus, Collinesella, Dorea, Escherichia, Parabacteroides, and Phascolarctobacterium, while the 
abundance of Balutia and Lachnospiracea incertae sedis were significantly decreased during fermentation.  
Carbohydrate fermentation and microbial metabolite production were correlated with bacterial 
populations after fermentation (Fig. 4). Taxa from the Lachnospiraceae family, including 
Coprococcus, Dorea, Lachnospiracea incertae sedis , and Roseburia, and the Ruminococcaceae 
family, including Faecallibacterium and Butyricicoccus, exhibited positive correlations with butyrate 
production. Bifidobacterium were negatively correlated with butyrate production. Clostridium XI was 
positively correlated with iso-butyrate, iso-valerate, and BCFAs production. Roseburia and Parasutterella 
were negatively correlated with iso-butyrate, iso-valerate, BCFAs, and ammonia production.  
5. Discussion 
Our previous study showed that the consumption of plant based nutrients influenced the 
functionality of the gut microbiota during fermentation (i.e., production of propionate, butyrate, ammonia 
and BCFA) [7], while we did not observe correlations between the gut microbiota composition and those 
plant-based nutrients. This suggested that the impacts of long-term diet on the function of the gut 
microbiota might be more preserved compared with the gut microbiota composition. Consistent with our 
results, Daniel et al. has shown the impact of diet on the chemical metabolites of microbiota was greater 
than the impact of gut microbiota composition, suggesting that diet might exert a  more pronounced impact 
on the functional level of gut microbiota [14]. Indeed, Zhang et al. described a core gut microbiota from 
healthy subjects, which was made up of a small number of genus-level phylotypes. Interestingly, these core 
phylotypes showed a common function of producing SCFA [15]. Turnbaugh et al and The Human 
Microbiome Project Consortium also showed a ‗core microbiome‘ at the functional level, rather than at the 
organismal lineage, and the deviations from this core may result in disease states [16, 17]. Core metabolic 
functions of the gut microbiota is important because even distantly related bacteria share similar key 
metabolic functions, and thus these key metabolic functions are directly related to health or disease, rather 
than core microbial community [18]. Closely related lineages are considered to compete against each other 
because of the overlapping habitats and ecological roles, however, the microbiota with similar functions 
have been shown to be likely co-existing in the same niche [19]. For instance, Faecalibacterium and 





other [15].  Thus, we did not observe significant correlations between dietary nutrients and individual genus; 
it is likely that the correlations between dietary pattern and the cluster of gut microbiota with similar 
functions would be observed. Unfortunately, gene expression data that show the function of gut micriota 
were not obtained in the present study. 
Given the importance of gut microbiota function, the metabolites of bacterial taxa were 
investigated using correlation analysis. It was worth noting that these correlations were obtained in the 
context of predigested whole wheat fermentation. Thus, the results also showed the types of bacteria that 
are specifically selected for by whole wheat. Our analyses revealed a positive relationship between the 
arabinoxylan utilization and Dialister. This is supported by recent findings showing that Dialister exhibited 
a gradual increase according to the whole grain dose [20]. High fecal Dialister levels were also identified in 
subjects that showed an anti-inflammatory response to a whole grain diet [21].  
SCFAs are produced as a result of carbohydrate fermentation and are beneficial to gut health. In 
particular, butyrate might improve gut epithelia function and insulin sensitivity [6]. Upon fermentation of 
pre-digested whole wheat flour, Faecallibacterium and Butyricicoccus exhibited positive correlations with 
butyrate production. This finding was in accordance with previous research that showed Faecallibacterium 
and Butyricicoccus are the most important butyrate-producing bacteria in the gut [22]. Members of the 
Lachnospiraceae family were also positively correlated with butyrate production.  Members of 
this family have been associated with obesity and protection from colon cancer in vivo by enhancing the 
production of butyric acid [23]. It is interesting to consider why there was a negative correlation of 
Bifidobacterium with butyrate production. Typically, increases in bifidobacteria are accompanied by a 
butyrogenic effect. While Bifidobacterium themselves do not produce butyrate, other commensal microbes 
can produce butyrate from lactate or polysaccharide breakdown products released by Bifidobacterium 
through cross-feeding [24]. However, other factors may also affect the butyrogenic bacteria. For instance, 
the competition for carbohydrate substrates with other nonbutyrogenic bacteria, such as Bacteroides, may 
result in a net decrease in butyrate production [25]. This is consistent with the increase of Bacteroides 
observed in our study and may explain the negative correlation of Bifidobacterium with butyrate production. 
Protein fermentation is recognized to be detrimental to gut health. Protein fermentation results in 





were positively correlated with iso-butyrate, iso-valerate, and BCFAs, suggesting that conditions that favor 
blooms in Clostridium XI might result in more undesirable fermentation products. Clostridium difficile, a 
pathogen that is a member in Clostridium XI, can use amino acid fermentation in order to create ATP as a 
source of energy [26]. Roseburia and Parasutterella were negatively correlated with iso-butyrate, iso-
valerate, BCFAs, and ammonia, suggesting their potential benefits on gut health. They may compete with 
some bacterial taxa that ferment protein and thereby reduce fermentation of protein. The increased 
Roseburia have been associated with improved metabolic diabetes and hepatic steatosis [27], whereas a low 
Parasutterella levels were observed in patients with inflammatory bowel disease [28].  
The fermentation of pre-digested whole wheat flour resulted in a significant increase in 
Bifidobacterium, which is consistent with human studies [29, 30]. Bifidobacterium have been regarded as a 
marker for intestinal health. For instance, supplementation of Bifidobacterium have been reported to reduce 
the risk of obesity [31]. We also observed a decrease in Desulfovibrio. Desulfovibrio prefers a slightly 
alkaline environment to grow, while Bifidobacterium may inhibit its growth by decreasing the luminal pH 
through SCFA production or by producing antimicrobial peptides that targeted Desulfovibrio [32]. The 
decrease in Desulfovibrio is potentially important for gut health because Desulfovibrio are endotoxin-
producing bacteria that are enriched in animals with impaired glucose tolerance [33]. Changes in other 
microbial genera were also observed, such as the increase in Butyricicoccus. Although research on this 
genus is limited, it has been reported that maize arabinoxylan can increase Butyricicoccus and the 
administration of Butyricicoccus has been linked to reduced colitis and improvement in epithelial barrier 
function by decreasing the TNF-α and IL-12 [34]. 
6. Conclusions 
We did not observe significantly positive correlations between specific gut microbiota taxa and the 
nutrients that have been shown to be associated with the function of the gut microbiota from our previous 
study. This suggested that the impacts of long-term diet on the function of the gut microbiota might be 
more preserved compared with the gut microbiota composition. The potential metabolic function of 
bacterial taxa in the context of whole wheat fermentation was investigated using correlation analysis. 
Butyrate production was significantly correlated with the abundance of Butyricicoccus, Coprococcus, 





negative correlations with the abundance of Roseburia and Parasutterella. This study has also revealed the 
changes of gut microbiota with health benefits after in vitro fermentation of predigested whole wheat flour. 
Most notably, Bifidobacterium, an indicator for gut health, and Butyricicoccus, a butyrate producer, were 
enhanced by pre-digested whole wheat flour.  
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Figure 2. Fecal bacterial communities clustered using PCA analysis of OTU at baseline and after in vitro fermentation (A); the loadings on PC1with significant 
correlations (B).  Numbers represent bacterial communities from different fecal donors; the triangle represents bacterial communities at baseline; the circle 











Figure 3. Abundance of bacterial taxa at baseline and after in vitro fermentation. *Significantly different from the abundance of bacterial taxa at baseline 










Figure 4. Correlations between the relative abundance of bacterial taxa  after in vitro fermentation and dietary fiber degradation and short-/branched-chain fatty 








 For the first study (chapter 2), we hypothesized that FOPS from maize would be more bifidogenic 
and support bacterial fermentation the longest and produce the highest SCFA compared with FOPS from 
wheat, thus possibly contributing to a colonic environment that is less susceptible to disease. We 
determined treatment temperatures for production of FOPS from maize bran and wheat bran and then 
determined the fermentation properties of partially purified FOPS from maize bran and wheat bran. 
Although FOPS from wheat bran was more bifidogenic than that from maize, in vitro human fecal 
fermentations indicated that maize FOPS resulted in enhanced production of SCFA, especially butyrate, 
compared with fructans and FOPS produced from wheat bran. Additionally, maize FOPS showed 
significantly higher antioxidant activity because of the high ferulic acid content.  
For the second study (chapter 3), we hypothesized that unique structural diversity coupled with the 
presence of antioxidants in FOPS would aid in the improvement of insulin response and lipid profile, 
alleviating inflammation syndromes, sustaining prolonged bacterial fermentation, and altering the gut 
microbiota to a healthier state. We selected maize FOPS to test whether the consumption of maize-derived 
FOPS could counteract deleterious metabolic effects of HF-feeding through modulating the gut microbiota 
in mice. We observed that mice in the FOPS treatment exhibited disparate metabolic responses to it. Our 
results suggest that colonic fermentation of FOPS plays an important role in preventing metabolic disorders 
in HF-fed mice, and that these metabolic improvements depend on specific alterations of the gut microbiota 
through FOPS fermentation. Blautia and Akkermansia might be considered potential therapeutic targets for 
improving body and adipose tissue weights, while we speculated SCFA production seems linked to 
improvements in glucose metabolism. However, it is unclear why the mice in the FOPS group responded so 
differently to the treatment. We further hypothesized that functional microbial differences at the strain level 
are responsible for the disparate responses to dietary FOPS in mice. Future studies should determine the 
functional microbial differences at the strain level between these FOPS mice. 
For the third study (chapter 4), we hypothesized that diet would impact the extent of dietary fiber 
utilization and the types of metabolic end-products produced by the microbiota during in vitro fecal 






and SCFA/BCFA and ammonia production during in vitro fecal fermentation. We found that butyrate 
production was correlated with fecal donor intake of many nutrients of which principal component analysis 
revealed were mostly contributed by grain-, nut-, and vegetable-based foods. These results suggest that 
diets high in plant-based foods and high in unsaturated fats are associated with microbial metabolism that is 
consistent with host health. 
For the fourth study (chapter 5), we hypothesized that long-term dietary pattern and the 
fermentation of whole grain wheat would influence the gut microbiota composition. We then determined 
the influence of long-term dietary pattern and the fermentation of whole grain wheat on the gut microbiota 
composition. We found butyrate production was significantly correlated with the abundance of 
Butyricicoccus, Coprococcus, Dorea, Faecalibacterium, and Lachnospiracea incertae sedis. 
Bifidobacterium and Butyricicoccus were enhanced by pre-digested whole wheat flour. However, we did 
not observe significantly positive correlations between specific gut microbiota taxa and the nutrients that 
have been shown to be associated with the function of the gut microbiota from our previous study. This 
suggested that the impacts of long-term diet on the function of the gut microbiota might be more preserved 
compared with the composition of the gut microbiota. Thus, we further hypothesize that dietary pattern 
impacts the function of the gut microbiota. To test this hypothesis, future studies should determine the 
impacts of long-term diet on the function (based on metabolite profiling and gene expression) and gut 



















Appendix 1. Cereal Grain Projects. 
Polysaccharide composition of triticale produced over three years in the Great Plains of the USA 
 
Abstract 
Triticale, a man made hybrid of durum wheat and rye, is mostly used for animal feed. It merges the yield 
potential and grain quality of wheat and the environment tolerance of rye. However, the limited market for triticale 
can discourage many farmers from planting it. Thus, given the beneficial effects of dietary fibers and the potential 
for starch conversion to ethanol, characterizing the polysaccharide fractions in triticale may help expand the triticale 
market to food and energy industries. To accomplish this, twelve experimental lines of winter triticale grown over 
three consecutive years were characterized for starch, β-glucan, and water extractable and water unextractable 
arabinoxylan (WE-AX and WU-AX). Our results showed starch, β-glucan, WE-AX, and WU-AX ranged from (% 
dm) 55.5 to 65.2, 0.48 to 0.91, 0.76 to 1.3, and 4.1 to 6.5, respectively. Some genotypes were less variable across 
production year than others, suggesting that some lines may be selected to breed for certain polysaccharides. The 
concentration of WE-AX and WU-AX was highly negatively correlated with grain yield. Our data may help growers 
and plant breeders select genetically stable cultivars with high starch or beneficial bioactive polysaccharides, thereby 
enhancing the application of triticale in energy and food industries. 
 





Triticale (×Triticosecale Wittmack), a cross of wheat (Triticum durum L.) and rye (Secale cereale L.), was 
developed to harness the yield potential of wheat and the adaptability of rye.  However, the utilization of triticale has 
been limited primarily to animal feed; it is seldom used in bread industry or for bioethanol production (Obuchowski, 
Banaszak, Makowska, & Łuczak, 2010). 
 The polysaccharides in triticale consist of starch and dietary fibers [cellulose, arabinoxylan (AX) and β-
glucan]. Starch is the major storage polysaccharide of triticale and varies from 59-72% of the weight of the grain 
(Burešov , Sedl čkov , Faměra, & Lipavský, 2010; Rakha, Åman, & Andersson, 2011). Dietary fiber content of 
triticale (13-16%; Rakha et al., 2011) lies between wheat (10.5-13.9%; Gebrurs et al., 2008) and rye (14.7-20.9%; 
Nystr m et al., 2008). The dietary fibers in triticale include arabinoxylan (AX) as the most abundant component 
(5.9-7.5%), followed by cellulose (1.9-2.5%), and then a small amount of β-glucan (0.5-1%) (Rakha et al., 2011). 
AX is composed of a (1, 4)-linked β-d-xylopyranosyl backbone with α-L-arabinofuranosyl moieties substituted at 
C(O)-2 and/or C(O)-3 (Delcour & Hoseney, 2010). AX can be categorized based on water extractability into water-
extractable (WE-AX) or water-unextractable (WU-AX). β-Glucan is a minor component of the starchy endosperm 
and aleurone cell wall of cereals, and consists of β-D-glucopyranosyl units linked through (1, 4) and (1, 3) 
glycosidic bonds (Delcour et al., 2010). Because of its limited bioactivity, cellulose was not addressed in this study.  
The polysaccharide content in triticale has only been studied in few cases (Dennett, Wilkes, & Trethowan, 
2013; Rakh et al., 2011; Saini & Henry, 1989). However, no studies have been carried out using multiple triticale 
lines produced over several years in the Great Plains, an area of the US covering, Nebraska, South Dakota, North 
Dakota, and parts of Colorado, Kansas, Montana, New Mexico, Oklahoma, Texas, and Wyoming. The objective of 
this study was to characterize the major polysaccharides in triticale over three consecutive years, thereby providing 
plant breeders and producers information on selecting useful cultivars in this region.  
2. Materials & methods 
2.1. Triticale samples 
   Ten experimental triticale lines, NT01451, NT10417, NT09423, NT10429, NT05429, NT09404, 
NT06427, NT07403, NT06422, and NT05421, and two cultivars, NE422T (Baenziger & Vogel, 2003), NT426GT 
(Baenziger, Jannink, & Gibson, 2005), were obtained from the small grains breeding program at the University of 




consecutive years (2011, 2012, and 2013). After harvest, the triticale samples were milled with a cyclone sample 
mill equipped with a 1 mm screen (UDY, Boulder, CA USA). 
 2.2. Weather information 
 High/low temperature and total rainfall over the study period was provided by the state climatologist in the 
School of Natural Resources, University of Nebraska-Lincoln (Lincoln, NE USA). Data were collected from a 
climatology station located 0.96 km from the field site.  
2.3. Polysaccharide analysis 
 Samples were analyzed for moisture (Approved Method 44-15A, AACC International, 2000) and starch 
(K-TSTA, Megazyme, Bray, Ireland). β-Glucan was quantified using a mixed-linkage β-glucan kit (K-BGLU, 
Megazyme, Bray, Ireland). AX was measured as WE-AX and WU-AX by gas chromatography (GC) of alditol 
acetates obtained after acid hydrolysis. The separation and hydrolysis steps were based on the method described by 
Frederix et al. (2004) except using 0.4 M H2SO4 at 121 
o
C to hydrolyze the samples, while the derivatization step 
was performed according to Approved Method 32-25 (AACC International, 2000) with some modifications: 1) 5 μl 
of 2-octanol was added before the reduction step to reduce the loss of ammonium hydroxide, and 2) reduction time 
was prolonged to 1.5 h. The WE-AX content was calculated according to the following equation: mmol WE-AX = 
mmol arabinose – 0.7*mmol galactose + mmol xylose to account for arabinose in arabinogalactan peptide 
(Ingelbrecht, Verwimp, Grobet, & Delcour, 2001). WU-AX was the sum of arabinan and xylan in the insoluble 
dietary fiber fraction. The arabinose/xylose ratio (A/X) was calculated as the ratio of arabinan to xylan in each AX 
fraction. 
2.4. Data analysis 
        All analyses were performed in duplicate. All statistical comparisons were performed using SAS software 
(version 9.4, SAS Institute, Cary, NC). Differences in polysaccharide compositions were analyzed using analysis of 
variance (ANOVA) in combination with Fisher‘s protected least significant difference test. No plot replication was 
included, therefore only the main effects of genotype and year were included in the ANOVA model. Because the 
year to year variation is usually much larger than plot to plot variation, it is appropriate to assess genotype difference 
by analyzing over years (Sweley, Rose, & Jackson, 2012). Pearson's correlation coefficients were computed for 
agronomic and polysaccharide data. P<0.05 was used to consider statistical significance. 




3.1. Growth and harvest information of different triticale lines 
 Year 2 was a particularly unusual year with regard to the earlier heading date compared with others (Table 
1). Year 1 experienced the highest amount of rainfall followed by year 2 and then year 3 (Fig. 1). Higher 
temperature fluctuation was also observed in year 1 and year 3 over year 2. The earlier heading date of wheat 
exhibits a positive correlation with daily minimum temperatures during the spring season (Hu, Weiss, Feng, & 
Baenziger, 2005), in agreement with the temperature data shown in Fig. 1. 
3.2. Starch 
 Total starch content in different genotypes over three years varied between 55.5 and 65.2% (Table 2), 
slightly lower than the values reported previously (59.2-72.9%; Rakha et al., 2011; Burešov  et al., 2010). The 
variation may be explained by use of different genetic lines, production practices, production location, and year 
(Obuchowski et al., 2010).  
The starch content in cereal grains has been shown to be strongly influenced by weather conditions. 
Generally, warm weather and higher rainfall lead to higher kernel starch content (Burešov  et al., 2010). The 
weather may change the starch accumulation in cereals by acting on starch biosynthesis enzymes involved in chain 
elongation, branching, and granule crystallinity (Beckles & Thitisaksakul, 2014). Considerable year to year variation 
was observed in the total starch content, with year 3 significantly lower than year 1 and year 2 (Table 2).  Less total 
rainfall in 2013 (Fig. 1) may account for the low starch content (poorer grain fill) observed in this year.   
 The genotypic response of starch content in triticale over different years varied considerably. Although a 
decrease in starch content was observed for most lines in year 3 compared with the other years, some stayed 
unchanged and others even increased (Table 2). NT01451 and NT06422 were the most consistently high in starch 
over three years (high means coupled with low standard deviation over year). This suggests that these lines may be 
stable to different environmental conditions and used as genetic stock to develop new cultivars that are high in 
starch. High starch content would be desirable for triticale designed for animal feed (Theurer, 1986) or bioethanol 
production (Obuchowski et al., 2010). 
 3.3. β-Glucan  
 β-glucan content over three years ranged from 0.48-0.91% (Table 2), in agreement with values reported 
previously (0.5-1.0%; Rakha et al., 2011). Compared with its parent cereals, the total β-glucan content fell into 




  Harvest year had considerable influence on total β-glucan content, with highest values observed in year 1 
and lowest in year 2 (Table 2).  The significant impact of weather conditions in different years on β-glucan content 
has been reported (Fastnaught, Berglund, Holm, & Fox, 1996; Hang, Obert, Gironella, & Burton, 2007; G. Zhang, 
Chen, Wang, & Ding, 2001). For instance, in barley high temperature leads to increased β-glucan content, which 
may also apply to triticale (Fastnaught et al., 1996). The high temperature fluctuation in years 1 and 3 over year 2 
may partly account for their significantly higher β-glucan content. Hansen et al. (2003) reported lower β-glucan 
content in rye during rainy years. We did not observe this trend in our study, indicating the association between 
rainfall and β-glucan content in triticale may be different from rye or that the timing of rain during seed development 
is important for β-glucan concentration.  
 Maximum β-glucan content was detected on NT06427, whereas NE422T, NT09423, NT10429, and 
NT426GT displayed low β-glucan content over the study period (Table 2). For food use, high β-glucan is preferred 
because of its beneficial health effects on blood cholesterol (Welch, Webster, & Wood, 2011). Although the β-
glucan content in triticale is notably lower than oats (~5%) (Welch et al., 2011), β-glucan consumption as low as 20 
mg/d were enough to have physiological effects on human health (Samuelsen, Schrezenmeir, & Knutsen, 2014). 
3.4. Arabinoxylan 
 WE-AX concentration varied from 0.76-1.3%, while WU-AX varied from 4.1-6.5%.  (Table 2). This WE-
AX concentration is slightly higher than those found in the literature (0.55%; (Dennett, Wilkes, & Trethowan, 2013; 
Rakha et al., 2011; Saini & Henry, 1989); however, consistent with previous reports, the total AX in triticale has 
been reported by others as 4.4-7.5% (Rakha et al., 2011), which is in consistent with our results. As with the β-
glucan data, the AX content of triticale was more similar to wheat (WE-AX: 0.5-0.8%; WU-AX: 3.7-4.6%) 
(Gebruers et al., 2008) than rye (WE-AX: 1.5-3.0%; WU-AX: 5-8.5%) (Nystr m et al., 2008). NT01451 and 
NT09404 showed the highest WE-AX concentration, while several genotypes displayed low WE-AX 
concentrations.  
WE-AX has been studied for its health-promoting effects. For instance, WE-AX from wheat has been 
shown to reduce postprandial glucose responses (Lu, Walker, Muir, Mascara, & O'Dea, 2000) and promote 
beneficial gut microbiota in the colon (Neyrinck et al., 2011). However, in some applications WE-AX is 





NT07403 and NT09404 showed the highest WU-AX concentration, while low concentrations were found 
in NT05421 and NT10429. Except for its value as a source of dietary fiber, most applications are improved by 
reducing WU-AX concentration (Dornez, Gebruers, Delcour, & Courtin, 2009). 
With regard to year, higher contents of WE-AX and WU-AX were observed in years 2 and 3 compared 
with year 1 (Table 2). The content of WE-AX in wheat has been negatively associated with temperature and 
positively with rainfall due to the high endoxylanase activity under cool and wet conditions, resulting in the 
breakdown of WU-AX into its soluble counterpart (Gebruers et al., 2010). However, in another study the opposite 
trends have been shown (Zhang et al., 2010). Our results are in line with the latter study, since higher rainfall was 
recorded in the year with low WE-AX content.   
3.5. Correlations of polysaccharide content with yield 
A significant correlation was found between grain yield and WE-AX and WU-AX content (Table 3). 
Dornez et al. (2008) did not find any significant correlation between these parameters in wheat, suggesting 
differences between AX fractions in triticale versus wheat. This correlation might be used in a breeding program to 
select desirable polysaccharide compositions. 
4. Conclusions 
 Our study characterized the polysaccharide content and evaluated the environmental and genetic effects on 
experimental triticale varieties over three years, providing valuable information for both breeders and food 
manufactures. For instance, the genotypes with stable high starch content may become potential candidates for 
ethanol production, while the genotypes with stable high β-glucan or WE-AX can be selected as targets to produce 
functional food with enhanced health benefits. The heredity of these traits can be studied to produce novel cultivars 
in the future. 
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Table 1. Heading date and grain yield for triticale over three production years. 
Genotype 
Year 1   Year 2   Year 3 
Heading date Yield (kg/ha)   Heading date Yield (kg/ha)   Heading date Yield (kg/ha) 
NT01451 26-May 5948   6-May 4829  30-May 2937 
NT10417 24-May 6738  3-May 5149  29-May 3840 
NT09423 27-May 6643  6-May 5405  30-May 4220 
NT10429 28-May 6268  5-May 4652  30-May 3667 
NT05429 23-May 6339  26-Apr 4577  28-May 4334 
NT09404 28-May 6206  6-May 4854  29-May 3490 
NE422T 29-May 5146  8-May 4441  31-May 2937 
NT426GT 25-May 6269  3-May 5037  29-May 2780 
NT06427 25-May 5561  30-Apr 4660  29-May 3366 
NT07403 22-May 6406  22-Apr 5020  27-May 4806 
NT06422 22-May 6352  26-Apr 4952  29-May 4688 









Table 2. Polysaccharide content of triticale lines over three years.
a 
Effect Starch   β-Glucan   WE-AX   A/XWE-AX   WU-AX   A/XWU-AX 
Level Mean SD LSD0.05   Mean SD LSD0.05   Mean SD LSD0.05   Mean SD LSD0.05   Mean SD LSD0.05   Mean SD LSD0.05 
Genotype 
                       NE422T 59.3 2.8 b-d 
 
0.482 0.073 e 
 
0.890 0.166 b-d 
 
0.66 0.01 c 
 
4.64 0.36 d-f 
 
0.77 0.15 bc 
NT01451 60.1 2.1 bc 
 
0.692 0.170 bc 
 
1.30 0.07 a 
 
0.78 0.25 ab 
 
5.32 1.09 c 
 
0.74 0.05 bc 
NT05421 56.4 1.9 de 
 
0.757 0.058 b 
 
0.879 0.326 b-e 
 
0.66 0.02 c 
 
4.44 1.22 ef 
 
0.75 0.02 bc 
NT05429 60.9 5.7 bc 
 
0.683 0.147 b-d 
 
0.916 0.043 b-d 
 
0.82 0.30 a 
 
4.62 1.28 d-f 
 
0.79 0.09 ab 
NT06422 60.4 1.9 bc 
 
0.763 0.079 b 
 
0.814 0.284 de 
 
0.64 0.06 c 
 
4.83 1.78 c-e 
 
0.74 0.03 bc 
NT06427 55.5 4.0 e 
 
0.906 0.023 a 
 
0.758 0.229 e 
 
0.61 0.04 c 
 
5.45 1.75 bc 
 
0.71 0.03 bc 
NT07403 62.5 5.2 ab 
 
0.649 0.138 cd 
 
0.930 0.139 b-d 
 
0.68 0.16 bc 
 
6.51 0.99 a 
 
0.76 0.10 bc 
NT09404 58.4 1.4 c-e 
 
0.609 0.056 d 
 
1.22 0.32 a 
 
0.69 0.12 bc 
 
6.03 1.24 ab 
 
0.72 0.01 bc 
NT09423 62.6 4.1 ab 
 
0.474 0.095 e 
 
0.947 0.257 b-d 
 
0.63 0.02 c 
 
5.29 1.42 cd 
 
0.67 0.09 c 
NT10417 61.2 2.1 bc 
 
0.692 0.157 bc 
 
0.863 0.260 c-e 
 
0.65 0.01 c 
 
5.43 1.11 bc 
 
0.73 0.03 bc 
NT10429 61.0 5.0 bc 
 
0.492 0.085 e 
 
1.02 0.07 b 
 
0.67 0.12 bc 
 
4.14 1.66 f 
 
0.83 0.14 ab 
NT426GT 65.2 3.0 a 
 
0.477 0.057 e 
 
0.963 0.266 bc 
 
0.68 0.03 bc 
 
5.01 0.86 c-e 
 
0.91 0.28 a 
Year 
                       1 61.6 2.1 a 
 
0.712 0.139 a 
 
0.753 0.251 b 
 
0.77 0.18 a 
 
3.84 0.85 b 
 
0.74 0.11 b 
2 60.9 4.5 a 
 
0.558 0.177 c 
 
1.08 0.16 a 
 
0.63 0.04 b 
 
5.88 0.93 a 
 
0.81 0.16 a 
3 58.4 4.5 b  0.649 0.132 b  1.04 0.16 a  0.63 0.03 b  5.71 0.75 a  0.73 0.02 b 
a
Starch, β-glucan, water-extractable arabinoxylan (WE-AX) and water-unextractable arabinoxylan (WU-AX) expressed as % dry basis; A/XWE-AX and A/XWU-AX 
are molar ratios of arabinose to xylose present in each arabinoxylan type; LSD0.05 represents Fisher‘s least significant difference groupings at α=0.05 (significant 










Table 3. Correlations between heading date, yield, and polysaccharide fractions.
a
 
Variable Yield WE-AX A/XWE-AX WU-AX A/XWU-AX Starch β-Glucan 




 -0.271 -0.184 0.36* 
Yield 
 









   
-0.44** 0.159 0.214 0.217 
WU-AX 
    
-0.165 -0.165 -0.156 
A/XWU-AX 




Starch        -0.48** 
a
WE-AX, water-extractable arabinoxylan; WU-AX, water-unextractable arabinoxylan; A/X, arabinose/xylose; heading date calculated as day of the year; 
§










Fig. 1. Average temperature (℃) and total rainfall (mm) in three years of triticale growth; the high temperature is the solid shaded bar, and low temperature is 






Appendix 2. Correlations of long-term dietary pattern of fecal donor with in vitro fermentation 
properties of inulin and comparison with whole wheat substrate  
Introduction   
Previously, we reported the influence of fecal donor on in vitro fermentation properties of whole 
wheat substrate. Whole wheat was selected as the fermentation substrate because it contains complex and 
poorly fermented dietary fibers (e.g., cellulose, cross-linked arabinoxylan, and complex pectic substances) 
that typically make up the substrates for gut bacteria (11-20 g/d) in a typical American diet. We found that 
butyrate production was correlated with fecal donor intake of many nutrients contributed by grain-, nut-, 
and vegetable-based foods. The study indicated that diets high in plant-based foods and high in unsaturated 
fats were associated with microbial metabolism that is consistent with host health.  
In contrast to the dietary fibers in wheat, inulin is readily soluble and fermentable by the gut 
microbiota. In this study, we desired to determine the influence of the long-term diet of fecal donor on in 
vitro fermentation of inulin and compare these results with our previous results using whole wheat as a 
substrate.  
Materials and methods 
 HP inulin (~100%, average DP ≥ 23, Beneo, Germany) was used as the fermentation substrates for 
this study. Subjects, dietary records, stool sample collection, in vitro fermentation, and fermentation 
analyses were performed as described (chapter 3; Yang and Rose, 2014). 
Results and discussion 
The amount of inulin fermented over 12 h of in vitro fermentation was determined (Fig. 1). There 
was great variation in the ability of each fecal microbiota to utilize the substrate. The fecal microbiotas 
from subjects 7, 11, 19, and 24 were among the most able to ferment the inulin, whereas the fecal 
microbiotas from subjects 15, 21, and 98 used the least.  Interestingly, when whole wheat was used as the 
fermentation substrate, the fecal microbiotas from subjects 21 and 98 were among the most able to ferment 
the dietary fibers.  
In agreement with the percent inulin fermented, the SCFA production varied greatly among fecal 
microbiotas (Fig. 2). The total SCFA production (r=0.66, p=0.003), acetate production (r=0.61, p=0.007), 





microbiota from subject 1 produced the most total SCFA. The fecal microbiota from subject 11 produced 
much more butyrate than any other microbiota. 
Unlike the SCFA data, markers of protein fermentation did not correlate with the percentage of 
inulin fermented (p-values ranged from 0.23 to 0.93) but did show variation among fecal microbiotas (Fig. 
3). The fecal microbiota from most subjects produced relatively low concentrations of BCFA. In contrast, 
the fecal microbiota from subjects 12 and 21 produced high amounts of BCFAs. Production of these 
metabolites was highly correlated with ammonia production (p = 0.0003, 0.0007, and 0.001 for ammonia vs 
iso-butyrate, iso-valerate, and BCFA, respectively).  
Many significant positive correlations were discovered for acetate, propionate, butyrate, and the 
total SCFA production during fermentation (Fig. 4). Interestingly, butyrate showed a significant positive 
correlation with dietary fiber, starch, plant protein, phytic acid, niacin, folate, Fe, Mg, and Zn, which is 
consistent with the correlation analysis with whole wheat substrate. There were a few additional significant 
correlations with inulin that were not observed on whole wheat substrate, including vitamin C and vitamin 
B-12. In the case of acetate, propionate, and total SCFA, more significant correlations were observed with 
inulin than whole wheat substrate. Iso-valerate showed significant negative correlations with 
polyunsaturated fat intake, whereas ammonia showed significant negative correlations with energy, 
carbohydrate, starch, and thiamin intake. 
A few correlations were noted between certain food categories and carbohydrate fermented and 
metabolite production during fermentation (Fig. 5). Butyrate carried the most significant correlations, 
including positive correlations with ―total vegetables,‖ ―potatoes,‖ ―other vegetables,‖ and ―fish high in 
omega-3s‖ and a negative correlation with ―eggs.‖ The relevance of some of these correlations was limited 
due to low reported intake (e.g., ―potatoes,‖ ―fish high in omega-3s,‖ ―soy products,‖ and ―dry beans and 
peas‖) or limited range of intakes (e.g., ―whole grain‖ and ―eggs‖) in some of these food categories. 
We performed a correlation analysis for fermentation parameters during fermentation of inulin and 
wheat substrates (Fig. 6). Interestingly, the only significant correlation was observed between the 
production of butyrate in wheat and inulin substrate, but not in other SCFA and carbohydrate fermented. 





on fecal donor. It was worthy nothing that significant correlation was also observed between the production 
of BCFA in wheat and inulin substrate. 
Conclusion 
 Butyrate showed a significant positive correlation with dietary fiber, starch, plant protein, phytic 
acid, niacin, folate, Fe, Mg, and Zn, which is consistent with the correlation analysis with whole wheat 
substrate. In the case of acetate, propionate, and total SCFA, more significant correlations were observed 
with inulin than whole wheat substrate. We also found that relative butyrate production is independent of 










Fig.1. Carbohydrate fermentation during 12 hours of in vitro fecal fermentation. Error bars show SD; bars marked with different letters are significantly different; 









Fig.2 Branched-chain fatty acid and ammonia production during 12 hours of in vitro fecal fermentation. Error bars show SD; bars marked with different letters 









Fig.3. Short-chain fatty acid production during 12 hours of in vitro fecal fermentation. Error bars show SD; bars marked with different letters are significantly 









Fig.4. Spearman ρ correlation of dietary nutrient intake of the fecal donor with carbohydrate fermented (%) and metabolite production (mM) during in vitro fecal 
fermentation. Black bars indicate the direction (left, negative; right, positive) and magnitude of significant (p<0.05; n=18) correlations when using inulin as 
substrate. Gray bars indicate the direction and magnitude of significant (p<0.05; n=18) correlations when using whole wheat as substrate. Data for whole wheat 








Fig.5. Spearman ρ correlation of food category intake of the fecal donor with carbohydrate fermented (%) and metabolite production (mM) during in vitro fecal 
fermentation. Black bars indicate the direction (left, negative; right, positive) and magnitude of significant (p<0.05; n=18) correlations when using inulin as 
substrate. Gray bars indicate the direction and magnitude of significant (p<0.05; n=18) correlations when using whole wheat as substrate. Data for whole wheat 









Fig.6. Correlation analysis for butyrate production during fermentation of inulin and whole wheat substrates. 
 
 
 
 
 
